Psyllid ID: psy5093


Local Sequence Feature Prediction

Prediction and (Method)Result
Residue Number Marker
Protein Sequence ?
Secondary Structure (PSIPRED) ?
Secondary Structure Prediction (SSPRO) ?
Coil and Loop (DISEMBL) ?
Flexible Loop (DISEMBL) ?
Low Complexity Region (SEG) ?
Disordered region (IsUnstruct) ?
Disordered Region (DISOPRED) ?
Disordered Region (DISEMBL) ?
Disordered Region (DISPRO) ?
Transmembrane Helix (TMHMM) ?
Transmembrane Helix (HMMTOP) ?
Transmembrane Helix (MEMSAT) ?
TM Helix, Signal Peptide (MEMSAT_SVM) ?
TM Helix, Signal Peptide (Phobius) ?
Signal Peptide (SignalP HMM Mode) ?
Signal Peptide (SignalP NN Mode) ?
Coiled Coils (COILS) ?
Positional Conservation ?
 
--------10--------20--------30--------40--------50--------60--------70--------80--------90-------100-------110-------120-------130-------140-------150-------160-------170-------180-------190-------200-------210-------220-------230-------240-------250-------260-------270-------280-------290-------300-------310-------320-------330-------340-------350-------360-------370-------380-------390-------400-------410-------420-------430-------440-------450-------460-------470-------480-------490-------500-------510-------520-------530-------540-------550-------560-------570-------580-------590-------600-------610-------620-------630-------640-------650-------660--
MELLPADFINNVDFFSNSSNWTYIDIDDDVVTYDFVSNFTLERWLELAQQRTLLVSTLSLFSLVTVFGNALVMIAVVRERYLHTSTNYFIMSLALADCLVGLVVMPFSALYELLDHNWIFGLNWCDSWRSLDVLFSTASILNLCVISLDRYWAITDPLTYPSRMSTRRAYIWIAIVWICSGGISFPAILWWRAVRNEEVPKNKCPFTDSKGYLIFSSTISFYLPLLVMVFTYFKIYRAAVVQTKSLKVGTKQVMSGSTSGEKELTLRIHRGGTDHRHMTLHHTPSDDVEMDNVMSGHNGITRQVSNTRIIHKGHIVKNFSLSRKLSKFAKEKKAAKTLGIVMGVFIVCWLPFFVVNLLSAVCTKCFWSEQDEELISAVVTWLGWINSGMNPVIYACWSRDFRSKEKILNHKISPVVFLLPMCMYPQYLVLISLCYYVTTLVLTAPAILWWRAVRNEEVPKNKCPFTDSKGYLIFSSTISFYLPLLVMVFTYFKIYRAAVVQTKSLKVGTKQVMSGSTSGEKELTLRIHRGGTDHRHMTLHHTPSDDVEMDNVMSGHNGITRQVSNTRIIHKGHIVKNFSLSRKLSKFAKEKKAAKTLGIVMGVFIVCWLPFFVVNLLSAVCTKCFWSEQDEELISAVVTWLGWINSGMNPVIYACWSRDFRR
cccccccccccccccccccccccccccccccccccccccccHHHHHHHHHHHHHHHHHHHHHHHHHHHccEEEEEEEccccccccHHHHHHHHHHHHHHHHHHcccHHHHHHHcccEEEccccccHHHHHHHHHHHHHHHHHHHHHHHHHHHHccccccccccccHHHHHHHHHHHHHHHHHHHHHHHHccccccccccccccccccccccEEEEEEHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHccccccccccccccccHHHcccccccccccccccccccccccccccccccccccccccccccccccccccccccccHHHHHHHHHHHHHHHHHHHHHHHHHcccHHHHHHHHHHHccccccccHHHHHHHHHHHHHccccccccHHHHHccHHHHHHHHHHHcccccccccccccccHHHHHHHHHHHHHHHHHHHHHHHHccccccccccccccccccccccEEEEEHHHHHHHHHHHHHHHHHHHHHHHHHHHHHccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccHHHHHHHHHHHHccccHHHHHHHHHHHHHcHHHHHHHHHHHHHcccccccccHHHHHHHHHHHHccccccccHHHHcccccccc
cccccccccccccccccccccccccccccccccccccccccccccccHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHcccccHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHcccEEccHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHcccccccccccHHHHHHHHHHHHHHHHHHccccccccccccccccccccccccccccEEHEHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHcccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHccccccccHHHHHHHHHHHHHHcccccEEEEcccHHHHHHHHHHHHHHccccccccccccHHHHHHHHHHHHHHHHHHHHHHHHHHHHccHHHccccccccEccHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHccccccccccHHHHHHHHHHHHHHcccccEEEEcccccHcc
mellpadfinnvdffsnssnwtyididddvvtydFVSNFTLERWLELAQQRTLLVSTLSLFSLVTVFGNALVMIAVVRERYLHTSTNYFIMSLALADCLVGLVVMPFSALYELLdhnwifglnwcdswRSLDVLFSTASILNLCVISLDRywaitdpltypsrmstRRAYIWIAIVWICSGGISFPAILWWRAVrneevpknkcpftdskgylifsSTISFYLPLLVMVFTYFKIYRAAVVQTkslkvgtkqvmsgstsgekELTLRIhrggtdhrhmtlhhtpsddvemdnvmsghngitrqvsntriiHKGHIVKNFSLSRKLSKFAKEKKAAKTLGIVMGVFIVCWLPFFVVNLLSAVCTKCFWSEQDEELISAVVTWLGwinsgmnpviyacwsrdfrskekilnhkispvvfllpmcmypqYLVLISLCYYVTTLVLTAPAILWWRAVrneevpknkcpftdskgylifsSTISFYLPLLVMVFTYFKIYRAAVVQTkslkvgtkqvmsgstsgekELTLRIhrggtdhrhmtlhhtpsddvemdnvmsghngitrqvsntriiHKGHIVKNFSLSRKLSKFAKEKKAAKTLGIVMGVFIVCWLPFFVVNLLSAVCTKCFWSEQDEELISAVVTWLGwinsgmnpviyacwsrdfrr
MELLPADFINNVDFFSNSSNWTYIDIDDDVVTYDFVSNFTLERWLELAQQRTLLVSTLSLFSLVTVFGNALVMIAVVRERYLHTSTNYFIMSLALADCLVGLVVMPFSALYELLDHNWIFGLNWCDSWRSLDVLFSTASILNLCVISLDRYWAITDPLTYPSRMSTRRAYIWIAIVWICSGGISFPAILWWRAVRNEEVPKNKCPFTDSKGYLIFSSTISFYLPLLVMVFTYFKIYRAAVVQTkslkvgtkqvmsgstsgekelTLRIHRGGTDHRHMTLHHTPSDDVEMDNVMSGHNGITrqvsntriihkghivknfslsrkLSKFAKEKKAAKTLGIVMGVFIVCWLPFFVVNLLSAVCTKCFWSEQDEELISAVVTWLGWINSGMNPVIYACWSRDFRSKEKILNHKISPVVFLLPMCMYPQYLVLISLCYYVTTLVLTAPAILWWRAVRNEEVPKNKCPFTDSKGYLIFSSTISFYLPLLVMVFTYFKIYRAAVVQTkslkvgtkqvmsgstsgekelTLRIHRGGTDHRHMTLHHTPSDDVEMDNVMSGHNGITrqvsntriihkghivknfslsrkLSKFAKEKKAAKTLGIVMGVFIVCWLPFFVVNLLSAVCTKCFWSEQDEELISAVVTWLgwinsgmnpvIYACWSRDFRR
MELLPADFINNVDFFSNSSNWtyididddvvtydFVSNFTLERWLELAQQRtllvstlslfslvtvfGNALVMIAVVRERYLHTSTNYFIMSLALADCLVGLVVMPFSALYELLDHNWIFGLNWCDSWRSLDVLFSTASILNLCVISLDRYWAITDPLTYPSRMSTRRAYIWIAIVWICSGGISFPAILWWRAVRNEEVPKNKCPFTDSKGYLIFSSTISFYLPLLVMVFTYFKIYRAAVVQTKSLKVGTKQVMSGSTSGEKELTLRIHRGGTDHRHMTLHHTPSDDVEMDNVMSGHNGITRQVSNTRIIHKGHIVKNFSLSRKLSKFAKEKKAAKTLGIVMGVFIVCWLPFFVVNLLSAVCTKCFWSEQDEELISAVVTWLGWINSGMNPVIYACWSRDFRSKEKILNHKISPVVFLLPMCMYPQYLVLISLCYYVTTLVLTAPAILWWRAVRNEEVPKNKCPFTDSKGYLIFSSTISFYLPLLVMVFTYFKIYRAAVVQTKSLKVGTKQVMSGSTSGEKELTLRIHRGGTDHRHMTLHHTPSDDVEMDNVMSGHNGITRQVSNTRIIHKGHIVKNFSLSRKLSKFAKEKKAAKTLGIVMGVFIVCWLPFFVVNLLSAVCTKCFWSEQDEELISAVVTWLGWINSGMNPVIYACWSRDFRR
*****ADFINNVDFFSNSSNWTYIDIDDDVVTYDFVSNFTLERWLELAQQRTLLVSTLSLFSLVTVFGNALVMIAVVRERYLHTSTNYFIMSLALADCLVGLVVMPFSALYELLDHNWIFGLNWCDSWRSLDVLFSTASILNLCVISLDRYWAITDPLTYPSRMSTRRAYIWIAIVWICSGGISFPAILWWRAVRNEEVPKNKCPFTDSKGYLIFSSTISFYLPLLVMVFTYFKIYRAAVVQTKSLKV**************************************************GITRQVSNTRIIHKGHIVKNFSLSRKLSKFAKEKKAAKTLGIVMGVFIVCWLPFFVVNLLSAVCTKCFWSEQDEELISAVVTWLGWINSGMNPVIYACWSRDFRSKEKILNHKISPVVFLLPMCMYPQYLVLISLCYYVTTLVLTAPAILWWRAVRNEEVPKNKCPFTDSKGYLIFSSTISFYLPLLVMVFTYFKIYRAAVVQTKSLKV**************************************************GITRQVSNTRIIHKGHIVKNFSLSRKLSKFAKEKKAAKTLGIVMGVFIVCWLPFFVVNLLSAVCTKCFWSEQDEELISAVVTWLGWINSGMNPVIYACWSR****
*********NNVDFFSNSSNWTYIDIDDDV*********TLERWLELAQQRTLLVSTLSLFSLVTVFGNALVMIAVVRERYLHTSTNYFIMSLALADCLVGLVVMPFSALYELLDHNWIFGLNWCDSWRSLDVLFSTASILNLCVISLDRYWAITDPLTYPSRMSTRRAYIWIAIVWICSGGISFPAILWWRAVRNEEVPKNKCPFTDSKGYLIFSSTISFYLPLLVMVFTYFKIYRAAV************************TLRIH***************************************************************KAAKTLGIVMGVFIVCWLPFFVVNLLSAVCTKCFWSEQDEELISAVVTWLGWINSGMNPVIYACWSRDFRSKEKILNHKISPVVFLLPMCMYPQYLVLISLCYYVTTLVLTAPAILWWRAVRNEEVPKNKCPFTDSKGYLIFSSTISFYLPLLVMVFTYFKIYRAAV***********************************************************************KGHIVK****************AAKTLGIVMGVFIVCWLPFFVVNLLSAVCTKCFWSEQDEELISAVVTWLGWINSGMNPVIYACWSRDFRR
MELLPADFINNVDFFSNSSNWTYIDIDDDVVTYDFVSNFTLERWLELAQQRTLLVSTLSLFSLVTVFGNALVMIAVVRERYLHTSTNYFIMSLALADCLVGLVVMPFSALYELLDHNWIFGLNWCDSWRSLDVLFSTASILNLCVISLDRYWAITDPLTYPSRMSTRRAYIWIAIVWICSGGISFPAILWWRAVRNEEVPKNKCPFTDSKGYLIFSSTISFYLPLLVMVFTYFKIYRAAVVQTKSLKV************EKELTLRIHRGGTDHRHMTLHHTPSDDVEMDNVMSGHNGITRQVSNTRIIHKGHIVKNFSLSRKLSKFAKEKKAAKTLGIVMGVFIVCWLPFFVVNLLSAVCTKCFWSEQDEELISAVVTWLGWINSGMNPVIYACWSRDFRSKEKILNHKISPVVFLLPMCMYPQYLVLISLCYYVTTLVLTAPAILWWRAVRNEEVPKNKCPFTDSKGYLIFSSTISFYLPLLVMVFTYFKIYRAAVVQTKSLKV************EKELTLRIHRGGTDHRHMTLHHTPSDDVEMDNVMSGHNGITRQVSNTRIIHKGHIVKNFSLSRKLSKFAKEKKAAKTLGIVMGVFIVCWLPFFVVNLLSAVCTKCFWSEQDEELISAVVTWLGWINSGMNPVIYACWSRDFRR
******************************************RWLELAQQRTLLVSTLSLFSLVTVFGNALVMIAVVRERYLHTSTNYFIMSLALADCLVGLVVMPFSALYELLDHNWIFGLNWCDSWRSLDVLFSTASILNLCVISLDRYWAITDPLTYPSRMSTRRAYIWIAIVWICSGGISFPAILWWRAVRNEEVPKNKCPFTDSKGYLIFSSTISFYLPLLVMVFTYFKIYRAAVVQTKSLK*************************************************************************LSRKLSKFAKEKKAAKTLGIVMGVFIVCWLPFFVVNLLSAVCTKCFWSEQDEELISAVVTWLGWINSGMNPVIYACWSRDFRSKEKILNHKISPVVFLLPMCMYPQYLVLISLCYYVTTLVLTAPAILWWRAVRNEEVPKNKCPFTDSKGYLIFSSTISFYLPLLVMVFTYFKIYRAAVVQTKSLKVGTKQVMS********************************************************************KLSKFAKEKKAAKTLGIVMGVFIVCWLPFFVVNLLSAVCTKCFWSEQDEELISAVVTWLGWINSGMNPVIYACWSRDF**
oooooooooooooooooooooooooooooooooooooooooooooooooooooHHHHHHHHHHHHHHHHHHHHHHHiiiiiiiiiiiiHHHHHHHHHHHHHHHHHHHHHHHoooooooooooooooooooHHHHHHHHHHHHHHHHHHiiiiiiiiiiiiiiiiiiiiHHHHHHHHHHHHHHHHHHHHHHHoooooooooooooooooooHHHHHHHHHHHHHHHHHHHHHHHiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiHHHHHHHHHHHHHHHHHHHHHHHooooooooooooooHHHHHHHHHHHHHHHHHHHHHHHiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiHHHHHHHHHHHHHHHHHHHHHHHoooooooooooooooooooHHHHHHHHHHHHHHHHHHHHHHHiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiHHHHHHHHHHHHHHHHHHHHHHHooooooooooooooHHHHHHHHHHHHHHHHHHHHHHHiiiiii
ooooooooooooooooooooooooooooooooooooooooooooooooooooHHHHHHHHHHHHHHHHHHHHHHHiiiiiiiiiiiiHHHHHHHHHHHHHHHHHHHHHHHooooooooooooooooooooHHHHHHHHHHHHHHHHHHiiiiiiiiiiiiiiiiiiiiHHHHHHHHHHHHHHHHHHHHHHHooooooooooooooooooooHHHHHHHHHHHHHHHHHHHHHHiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiHHHHHHHHHHHHHHHHHHHHHHHHooooooooooooHHHHHHHHHHHHHHHHHHHHHHHiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiHHHHHHHHHHHHHHHHHHHHHHHooooooooooooooooooooHHHHHHHHHHHHHHHHHHHHHHHiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiHHHHHHHHHHHHHHHHHHHHHHHHooooooooooooHHHHHHHHHHHHHHHHHHHHHHHHiiiiii
oooooooooooooooooooooooooooooooooooooooooooooooooooHHHHHHHHHHHHHHHHHHHHHHHHHiiiiiiiiiiiiHHHHHHHHHHHHHHHHHHHHHHHHoooooooooooHHHHHHHHHHHHHHHHHHHHHHHHHiiiiiiiiiiiiiiiiiiiHHHHHHHHHHHHHHHHHHHHoooooooooooooooooooooooooHHHHHHHHHHHHHHHHHHHHHHHHHiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiHHHHHHHHHHHHHHHHHHHHHHHHoooooooooooooooHHHHHHHHHHHHHHHHHHHHHHiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiHHHHHHHHHHHHHHHHHHHHooooooooooooooooooooooooooHHHHHHHHHHHHHHHHHHHHHHHHHiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiHHHHHHHHHHHHHHHHHHHHHHHHHooooooooooooooHHHHHHHHHHHHHHHHHHHHHHiiiiiiiii
ooooooooooooooooooooooooooooooooooooooooooooooooooHHHHHHHHHHHHHHHHHHHHHHHHHHHiiiiiiiiiHHHHHHHHHHHHHHHHHHHHHHHHoooooooooooooHHHHHHHHHHHHHHHHHHHHHHHHHiiiiiiiiiiiiiiiiiiiiiHHHHHHHHHHHHHHHHHHHoooooooooooooooooooooooHHHHHHHHHHHHHHHHHHHHHHHHiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiHHHHHHHHHHHHHHHHHHHHHHHHHHHHooooooooooooooHHHHHHHHHHHHHHHHHHiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiHHHHHHHHHHHHHHHHHHHHHHooooooooooooooooooooooHHHHHHHHHHHHHHHHHHHHHHHHiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiHHHHHHHHHHHHHHHHHHHHHHHHHHHoooooooooooooHHHHHHHHHHHHHHHHHHiiiiiiiiii
ooooooooooooooooooooooooooooooooooooooooooooooooooooHHHHHHHHHHHHHHHHHHHHHHHHiiiiiiiiiiiHHHHHHHHHHHHHHHHHHHHHHHHoooooooooooooooooooHHHHHHHHHHHHHHHHHHiiiiiiiiiiiiiiiiiiiiHHHHHHHHHHHHHHHHHHHHHHHoooooooooooooooooooHHHHHHHHHHHHHHHHHHHHHHHiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiHHHHHHHHHHHHHHHHHHHHHoooooooooooooooooooHHHHHHHHHHHHHHHHHHHHHHHHiiiiiiiiiiiiiiiiiiiiiiiiiiiiiHHHHHHHHHHHHHHHHHHHHHHHHoooooooooooooooooooHHHHHHHHHHHHHHHHHHHHHHHiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiHHHHHHHHHHHHHHHHHHHHHoooooooooooooooooooHHHHHHHHHHHHHHHHHHHHHHHHiiiiii
xxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxx
xxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxx
MELLPADFINNVDFFSNSSNWTYIDIDDDVVTYDFVSNFTLERWLELAQQRTLLVSTLSLFSLVTVFGNALVMIAVVRERYLHTSTNYFIMSLALADCLVGLVVMPFSALYELLDHNWIFGLNWCDSWRSLDVLFSTASILNLCVISLDRYWAITDPLTYPSRMSTRRAYIWIAIVWICSGGISFPAILWWRAVRNEEVPKNKCPFTDSKGYLIFSSTISFYLPLLVMVFTYFKIYRAAVVQTKSLKVGTKQVMSGSTSGEKELTLRIHRGGTDHRHMTLHHTPSDDVEMDNVMSGHNGITRQVSNTRIIHKGHIVKNFSLSRKLSKFAKEKKAAKTLGIVMGVFIVCWLPFFVVNLLSAVCTKCFWSEQDEELISAVVTWLGWINSGMNPVIYACWSRDFRSKEKILNHKISPVVFLLPMCMYPQYLVLISLCYYVTTLVLTAPAILWWRAVRNEEVPKNKCPFTDSKGYLIFSSTISFYLPLLVMVFTYFKIYRAAVVQTKSLKVGTKQVMSGSTSGEKELTLRIHRGGTDHRHMTLHHTPSDDVEMDNVMSGHNGITRQVSNTRIIHKGHIVKNFSLSRKLSKFAKEKKAAKTLGIVMGVFIVCWLPFFVVNLLSAVCTKCFWSEQDEELISAVVTWLGWINSGMNPVIYACWSRDFRR
no confident homologs detected

Close Homologs for Annotation Transfer

Close Homologs in SWISS-PROT Database Detected by BLAST ?

ID ?Alignment graph ?Length ? Definition ? RBH(Q2H) ? RBH(H2Q) ? Q cover ? H cover ? Identity ? E-value ?
Query662 2.2.26 [Sep-21-2011]
Q24563539 Dopamine receptor 2 OS=Dr yes N/A 0.489 0.601 0.632 1e-121
Q18775517 Dopamine receptor 4 OS=Ca yes N/A 0.569 0.729 0.355 4e-65
Q93126476 Probable G-protein couple N/A N/A 0.522 0.726 0.368 6e-62
P25100572 Alpha-1D adrenergic recep yes N/A 0.460 0.533 0.408 2e-60
Q91175470 Alpha-1A adrenergic recep N/A N/A 0.450 0.634 0.386 8e-60
P97717514 Alpha-1B adrenergic recep yes N/A 0.484 0.624 0.396 2e-59
P15823515 Alpha-1B adrenergic recep yes N/A 0.516 0.664 0.384 2e-59
P35368520 Alpha-1B adrenergic recep no N/A 0.457 0.582 0.403 7e-59
P18841515 Alpha-1B adrenergic recep N/A N/A 0.457 0.588 0.403 9e-59
Q64264421 5-hydroxytryptamine recep no N/A 0.531 0.836 0.355 1e-58
>sp|Q24563|DOPR2_DROME Dopamine receptor 2 OS=Drosophila melanogaster GN=DopR2 PE=2 SV=1 Back     alignment and function desciption
 Score =  436 bits (1120), Expect = e-121,   Method: Compositional matrix adjust.
 Identities = 237/375 (63%), Positives = 276/375 (73%), Gaps = 51/375 (13%)

Query: 65  TVFGNALVMIAVVRERYLHTSTNYFIMSLALADCLVGLVVMPFSALYELLDHNWIFGLNW 124
           TVFGN+LV++AV+RERYLHT+TNYFI SLA+ADCLVGLVVMPFSALYE+L++ W FG +W
Sbjct: 122 TVFGNSLVILAVIRERYLHTATNYFITSLAVADCLVGLVVMPFSALYEVLENTWFFGTDW 181

Query: 125 CDSWRSLDVLFSTASILNLCVISLDRYWAITDPLTYPSRMSTRRAYIWIAIVWICSGGIS 184
           CD WRSLDVLFSTASILNLCVISLDRYWAITDP +YP RM+ +RA   IA VWICS  IS
Sbjct: 182 CDIWRSLDVLFSTASILNLCVISLDRYWAITDPFSYPMRMTVKRAAGLIAAVWICSSAIS 241

Query: 185 FPAILWWRAVRNEEVPKNKCPFTDSKGYLIFSSTISFYLPLLVMVFTYFKIYRAAVVQTK 244
           FPAI+WWRA R+ E+P  KC FT+  GYL+FSSTISFYLPLLVMVFTY +IYRAAV+QT+
Sbjct: 242 FPAIVWWRAARDGEMPAYKCTFTEHLGYLVFSSTISFYLPLLVMVFTYCRIYRAAVIQTR 301

Query: 245 SLKVGTKQVMSGSTSGEKELTLRIHRGGT--DHRHM------------------------ 278
           SLK+GTKQV+    SGE +LTLRIHRGGT  D ++                         
Sbjct: 302 SLKIGTKQVLMA--SGELQLTLRIHRGGTTRDQQNQVSGGGGGGGGGGGGGGSLSHSHSH 359

Query: 279 -----------TLHHTPSDDVEMDNVMSGHNGITRQVSNTRIIHKGHIVKNFSLSRKLSK 327
                      T   TP +  +       +NG+ R        H+ H+ KNFSLSRKL+K
Sbjct: 360 SHHHHHNHGGGTTTSTPEEPDDEPLSALHNNGLAR--------HR-HMGKNFSLSRKLAK 410

Query: 328 FAKEKKAAKTLGIVMGVFIVCWLPFFVVNLLSAVCTKCFWSEQDEELISAVVTWLGWINS 387
           FAKEKKAAKTLGIVMGVFI+CWLPFFVVNLLS  C +C    + EE++SA+VTWLGWINS
Sbjct: 411 FAKEKKAAKTLGIVMGVFIICWLPFFVVNLLSGFCIECI---EHEEIVSAIVTWLGWINS 467

Query: 388 GMNPVIYACWSRDFR 402
            MNPVIYACWSRDFR
Sbjct: 468 CMNPVIYACWSRDFR 482




Receptor for dopamine. The activity of this receptor is mediated by G proteins which activate adenylyl cyclase. Also capable of generating a calcium signal. In terms of antagonist responses, would be classed with the D1-like dopamine receptor group. This receptor is an attractive candidate for initiating biochemical cascades underlying olfactory learning.
Drosophila melanogaster (taxid: 7227)
>sp|Q18775|DOPR4_CAEEL Dopamine receptor 4 OS=Caenorhabditis elegans GN=dop-4 PE=2 SV=2 Back     alignment and function description
>sp|Q93126|GPR9_BALAM Probable G-protein coupled receptor No9 OS=Balanus amphitrite PE=3 SV=1 Back     alignment and function description
>sp|P25100|ADA1D_HUMAN Alpha-1D adrenergic receptor OS=Homo sapiens GN=ADRA1D PE=2 SV=2 Back     alignment and function description
>sp|Q91175|ADA1A_ORYLA Alpha-1A adrenergic receptor OS=Oryzias latipes GN=adra1a PE=3 SV=1 Back     alignment and function description
>sp|P97717|ADA1B_MOUSE Alpha-1B adrenergic receptor OS=Mus musculus GN=Adra1b PE=1 SV=2 Back     alignment and function description
>sp|P15823|ADA1B_RAT Alpha-1B adrenergic receptor OS=Rattus norvegicus GN=Adra1b PE=2 SV=2 Back     alignment and function description
>sp|P35368|ADA1B_HUMAN Alpha-1B adrenergic receptor OS=Homo sapiens GN=ADRA1B PE=1 SV=3 Back     alignment and function description
>sp|P18841|ADA1B_MESAU Alpha-1B adrenergic receptor OS=Mesocricetus auratus GN=ADRA1B PE=1 SV=1 Back     alignment and function description
>sp|Q64264|5HT1A_MOUSE 5-hydroxytryptamine receptor 1A OS=Mus musculus GN=Htr1a PE=2 SV=2 Back     alignment and function description

Close Homologs in the Non-Redundant Database Detected by BLAST ?

GI ?Alignment Graph ?Length ? Definition ? Q cover ? H cover ? Identity ? E-value ?
Query662
322779267403 hypothetical protein SINV_02870 [Solenop 0.542 0.890 0.703 1e-137
383858579457 PREDICTED: dopamine receptor 2-like [Meg 0.543 0.787 0.712 1e-137
332023049402 Dopamine receptor 2 [Acromyrmex echinati 0.561 0.925 0.684 1e-137
307206398404 Dopamine receptor 2 [Harpegnathos saltat 0.543 0.891 0.699 1e-136
56044552475 dopamine receptor [Papilio xuthus] 0.557 0.776 0.678 1e-135
307181883404 Dopamine receptor 2 [Camponotus floridan 0.558 0.915 0.673 1e-135
340725553457 PREDICTED: dopamine receptor 2-like [Bom 0.543 0.787 0.701 1e-134
350415259469 PREDICTED: dopamine receptor 2-like [Bom 0.543 0.767 0.698 1e-134
380024653460 PREDICTED: dopamine receptor 2-like [Api 0.528 0.760 0.713 1e-134
58585084456 dopamine receptor 2 [Apis mellifera] gi| 0.530 0.769 0.707 1e-134
>gi|322779267|gb|EFZ09569.1| hypothetical protein SINV_02870 [Solenopsis invicta] Back     alignment and taxonomy information
 Score =  496 bits (1277), Expect = e-137,   Method: Compositional matrix adjust.
 Identities = 263/374 (70%), Positives = 304/374 (81%), Gaps = 15/374 (4%)

Query: 38  NFTLERWLELAQQRTLLVSTLSLFSLVTVFGNALVMIAVVRERYLHTSTNYFIMSLALAD 97
           N T +   ELA  R  L   L LF + TVFGN+LV++AV RER+LHT+TNYF+ SLA AD
Sbjct: 35  NHTYDDLWELATDRIGLAIVLLLFCVATVFGNSLVILAVFRERHLHTATNYFVTSLACAD 94

Query: 98  CLVGLVVMPFSALYELLDHNWIFGLNWCDSWRSLDVLFSTASILNLCVISLDRYWAITDP 157
           CLVGLVVMP SA+YE+L++ W+F  +WCD WRSLDVLFSTASILNLCVISLDRYWAITDP
Sbjct: 95  CLVGLVVMPISAVYEVLENRWLFTTDWCDVWRSLDVLFSTASILNLCVISLDRYWAITDP 154

Query: 158 LTYPSRMSTRRAYIWIAIVWICSGGISFPAILWWRAVRNEEVPKNKCPFTDSKGYLIFSS 217
            TYP+RMS +RA I IAIVWICS  ISFPAI WWRAVR E+VPK+KCPFT++ GYLIFSS
Sbjct: 155 FTYPTRMSRKRAAILIAIVWICSSAISFPAIAWWRAVRTEQVPKDKCPFTENLGYLIFSS 214

Query: 218 TISFYLPLLVMVFTYFKIYRAAVVQTKSLKVGTKQVMSGSTSGEKELTLRIHRGG----- 272
           TISFYLPL VMVFTY++IYRAAV+QT+SLK+GTKQVM    SGE ELTLRIHRGG     
Sbjct: 215 TISFYLPLFVMVFTYYRIYRAAVIQTRSLKLGTKQVMMA--SGELELTLRIHRGGVSTTN 272

Query: 273 TDHRHM--TLHHTPSDDVEMDNVMSG--HNGITRQVSNTRIIHKGHIVKNFSLSRKLSKF 328
           TD RH+  T   TP D  +++  ++   +NG+TR V +TRI +K H+ KNFSLSRKL+KF
Sbjct: 273 TDARHLFRTASSTPEDLQDLEEPLTAFHNNGLTR-VPSTRINNKQHLGKNFSLSRKLAKF 331

Query: 329 AKEKKAAKTLGIVMGVFIVCWLPFFVVNLLSAVCTKCFWSEQDEELISAVVTWLGWINSG 388
           AKEKKAAKTLGIVMGVFI+CWLPFFVVNLLS  CT+C W    EE++SA VTWLGWINSG
Sbjct: 332 AKEKKAAKTLGIVMGVFIICWLPFFVVNLLSGFCTRCIW---QEEMVSAAVTWLGWINSG 388

Query: 389 MNPVIYACWSRDFR 402
           MNPVIYACWSRDFR
Sbjct: 389 MNPVIYACWSRDFR 402




Source: Solenopsis invicta

Species: Solenopsis invicta

Genus: Solenopsis

Family: Formicidae

Order: Hymenoptera

Class: Insecta

Phylum: Arthropoda

Superkingdom: Eukaryota

>gi|383858579|ref|XP_003704778.1| PREDICTED: dopamine receptor 2-like [Megachile rotundata] Back     alignment and taxonomy information
>gi|332023049|gb|EGI63314.1| Dopamine receptor 2 [Acromyrmex echinatior] Back     alignment and taxonomy information
>gi|307206398|gb|EFN84440.1| Dopamine receptor 2 [Harpegnathos saltator] Back     alignment and taxonomy information
>gi|56044552|dbj|BAD72870.1| dopamine receptor [Papilio xuthus] Back     alignment and taxonomy information
>gi|307181883|gb|EFN69323.1| Dopamine receptor 2 [Camponotus floridanus] Back     alignment and taxonomy information
>gi|340725553|ref|XP_003401133.1| PREDICTED: dopamine receptor 2-like [Bombus terrestris] Back     alignment and taxonomy information
>gi|350415259|ref|XP_003490584.1| PREDICTED: dopamine receptor 2-like [Bombus impatiens] Back     alignment and taxonomy information
>gi|380024653|ref|XP_003696107.1| PREDICTED: dopamine receptor 2-like [Apis florea] Back     alignment and taxonomy information
>gi|58585084|ref|NP_001011567.1| dopamine receptor 2 [Apis mellifera] gi|20336615|gb|AAM19330.1|AF498306_1 dopamine receptor type D2 [Apis mellifera] Back     alignment and taxonomy information

Prediction of Gene Ontology (GO) Terms

Close Homologs with Gene Ontology terms Detected by BLAST ?

ID ? Alignment graph ? Length ? Definition ? Q cover ? H cover ? Identity ? E-value ?
Query662
FB|FBgn0015129539 DopR2 "Dopamine receptor 2" [D 0.348 0.428 0.683 1.3e-122
WB|WBGene00016872517 dop-4 [Caenorhabditis elegans 0.299 0.382 0.467 7.7e-68
UNIPROTKB|Q18775517 dop-4 "Dopamine receptor 4" [C 0.299 0.382 0.467 7.7e-68
UNIPROTKB|F1NIZ5376 ADRA1B "Uncharacterized protei 0.291 0.513 0.441 8.6e-62
ZFIN|ZDB-GENE-041114-51481 adra1bb "adrenergic receptor, 0.303 0.417 0.432 1.3e-61
UNIPROTKB|F1S8D0571 ADRA1D "Alpha-1D adrenergic re 0.312 0.362 0.436 1.5e-60
UNIPROTKB|Q9TTM9571 ADRA1D "Alpha-1D adrenergic re 0.312 0.362 0.436 1.5e-60
ZFIN|ZDB-GENE-090312-203491 adra1d "adrenergic receptor, a 0.338 0.456 0.398 6.4e-60
UNIPROTKB|F1NK17436 F1NK17 "Uncharacterized protei 0.291 0.442 0.431 1.1e-59
UNIPROTKB|F1MGA6515 ADRA1B "Uncharacterized protei 0.291 0.374 0.441 1.2e-59
FB|FBgn0015129 DopR2 "Dopamine receptor 2" [Drosophila melanogaster (taxid:7227)] Back     alignment and assigned GO terms
 Score = 833 (298.3 bits), Expect = 1.3e-122, Sum P(2) = 1.3e-122
 Identities = 160/234 (68%), Positives = 185/234 (79%)

Query:    41 LERWLE-LAQQRXXXXXXXXXXXXXXXXGNALVMIAVVRERYLHTSTNYFIMSLALADCL 99
             L  +LE L   R                GN+LV++AV+RERYLHT+TNYFI SLA+ADCL
Sbjct:    97 LSEFLEALPNDRVGLLAFLFLFSFATVFGNSLVILAVIRERYLHTATNYFITSLAVADCL 156

Query:   100 VGLVVMPFSALYELLDHNWIFGLNWCDSWRSLDVLFSTASILNLCVISLDRYWAITDPLT 159
             VGLVVMPFSALYE+L++ W FG +WCD WRSLDVLFSTASILNLCVISLDRYWAITDP +
Sbjct:   157 VGLVVMPFSALYEVLENTWFFGTDWCDIWRSLDVLFSTASILNLCVISLDRYWAITDPFS 216

Query:   160 YPSRMSTRRAYIWIAIVWICSGGISFPAILWWRAVRNEEVPKNKCPFTDSKGYLIFSSTI 219
             YP RM+ +RA   IA VWICS  ISFPAI+WWRA R+ E+P  KC FT+  GYL+FSSTI
Sbjct:   217 YPMRMTVKRAAGLIAAVWICSSAISFPAIVWWRAARDGEMPAYKCTFTEHLGYLVFSSTI 276

Query:   220 SFYLPLLVMVFTYFKIYRAAVVQTKSLKVGTKQVMSGSTSGEKELTLRIHRGGT 273
             SFYLPLLVMVFTY +IYRAAV+QT+SLK+GTKQV+  S  GE +LTLRIHRGGT
Sbjct:   277 SFYLPLLVMVFTYCRIYRAAVIQTRSLKIGTKQVLMAS--GELQLTLRIHRGGT 328


GO:0004952 "dopamine neurotransmitter receptor activity" evidence=ISS;NAS
GO:0005887 "integral to plasma membrane" evidence=ISM;NAS
GO:0007191 "adenylate cyclase-activating dopamine receptor signaling pathway" evidence=IDA
GO:0001588 "dopamine neurotransmitter receptor activity, coupled via Gs" evidence=ISS;NAS;IDA
GO:0005886 "plasma membrane" evidence=ISS
GO:0016021 "integral to membrane" evidence=IEA;ISS
GO:0007212 "dopamine receptor signaling pathway" evidence=ISS
GO:0008227 "G-protein coupled amine receptor activity" evidence=ISS
GO:0004935 "adrenergic receptor activity" evidence=IEA
GO:0071875 "adrenergic receptor signaling pathway" evidence=IEA
WB|WBGene00016872 dop-4 [Caenorhabditis elegans (taxid:6239)] Back     alignment and assigned GO terms
UNIPROTKB|Q18775 dop-4 "Dopamine receptor 4" [Caenorhabditis elegans (taxid:6239)] Back     alignment and assigned GO terms
UNIPROTKB|F1NIZ5 ADRA1B "Uncharacterized protein" [Gallus gallus (taxid:9031)] Back     alignment and assigned GO terms
ZFIN|ZDB-GENE-041114-51 adra1bb "adrenergic receptor, alpha 1bb" [Danio rerio (taxid:7955)] Back     alignment and assigned GO terms
UNIPROTKB|F1S8D0 ADRA1D "Alpha-1D adrenergic receptor" [Sus scrofa (taxid:9823)] Back     alignment and assigned GO terms
UNIPROTKB|Q9TTM9 ADRA1D "Alpha-1D adrenergic receptor" [Sus scrofa (taxid:9823)] Back     alignment and assigned GO terms
ZFIN|ZDB-GENE-090312-203 adra1d "adrenergic receptor, alpha 1d" [Danio rerio (taxid:7955)] Back     alignment and assigned GO terms
UNIPROTKB|F1NK17 F1NK17 "Uncharacterized protein" [Gallus gallus (taxid:9031)] Back     alignment and assigned GO terms
UNIPROTKB|F1MGA6 ADRA1B "Uncharacterized protein" [Bos taurus (taxid:9913)] Back     alignment and assigned GO terms

Prediction of Enzyme Commission (EC) Number

EC Number Prediction by Annotation Transfer from SWISS-PROT Entries ?

ID ?Name ?Annotated EC number ?Identity ?Query coverage ?Hit coverage ?RBH(Q2H) ?RBH(H2Q) ?
Q24563DOPR2_DROMENo assigned EC number0.6320.48940.6011yesN/A

EC Number Prediction by EFICAz Software ?

No EC number assignment, probably not an enzyme!


Prediction of Functionally Associated Proteins


Conserved Domains and Related Protein Families

Conserved Domains Detected by RPS-BLAST ?

ID ?Alignment Graph ?Length ? Definition ? E-value ?
Query662
pfam00001251 pfam00001, 7tm_1, 7 transmembrane receptor (rhodop 6e-45
pfam00001251 pfam00001, 7tm_1, 7 transmembrane receptor (rhodop 2e-15
pfam00001251 pfam00001, 7tm_1, 7 transmembrane receptor (rhodop 2e-15
PHA03087335 PHA03087, PHA03087, G protein-coupled chemokine re 3e-12
pfam00001251 pfam00001, 7tm_1, 7 transmembrane receptor (rhodop 2e-05
PHA02638417 PHA02638, PHA02638, CC chemokine receptor-like pro 2e-05
PHA02834323 PHA02834, PHA02834, chemokine receptor-like protei 0.001
>gnl|CDD|215646 pfam00001, 7tm_1, 7 transmembrane receptor (rhodopsin family) Back     alignment and domain information
 Score =  160 bits (407), Expect = 6e-45
 Identities = 60/187 (32%), Positives = 91/187 (48%), Gaps = 6/187 (3%)

Query: 74  IAVVRERYLHTSTNYFIMSLALADCLVGLVVMPFSALYELLDHNWIFGLNWCDSWRSLDV 133
           + ++R + L T TN F+++LA+AD L  L + P++  Y +    W FG   C     L V
Sbjct: 1   LVILRTKKLRTPTNIFLLNLAVADLLFLLTLPPWALYYLVGGD-WPFGDALCKLVGFLFV 59

Query: 134 LFSTASILNLCVISLDRYWAITDPLTYPSRMSTRRAYIWIAIVWICSGGISFPAILWWRA 193
           +   ASIL L  IS+DRY AI  PL Y    + RRA + I +VW+ +  +S P +L+   
Sbjct: 60  VNGYASILLLTAISIDRYLAIVHPLRYRRIRTPRRAKVLILVVWVLALLLSLPPLLFSWL 119

Query: 194 VRNEEVPKNKCPFTD-----SKGYLIFSSTISFYLPLLVMVFTYFKIYRAAVVQTKSLKV 248
              EE     C          + Y + S+ + F LPLLV++  Y  I R    + +S   
Sbjct: 120 RTVEEGNVTTCLIDFPEESTKRSYTLLSTLLGFVLPLLVILVCYTLILRTLRKRARSGAS 179

Query: 249 GTKQVMS 255
             +   S
Sbjct: 180 QARAKRS 186


This family contains, amongst other G-protein-coupled receptors (GCPRs), members of the opsin family, which have been considered to be typical members of the rhodopsin superfamily. They share several motifs, mainly the seven transmembrane helices, GCPRs of the rhodopsin superfamily. All opsins bind a chromophore, such as 11-cis-retinal. The function of most opsins other than the photoisomerases is split into two steps: light absorption and G-protein activation. Photoisomerases, on the other hand, are not coupled to G-proteins - they are thought to generate and supply the chromophore that is used by visual opsins. Length = 251

>gnl|CDD|215646 pfam00001, 7tm_1, 7 transmembrane receptor (rhodopsin family) Back     alignment and domain information
>gnl|CDD|215646 pfam00001, 7tm_1, 7 transmembrane receptor (rhodopsin family) Back     alignment and domain information
>gnl|CDD|222976 PHA03087, PHA03087, G protein-coupled chemokine receptor-like protein; Provisional Back     alignment and domain information
>gnl|CDD|215646 pfam00001, 7tm_1, 7 transmembrane receptor (rhodopsin family) Back     alignment and domain information
>gnl|CDD|165021 PHA02638, PHA02638, CC chemokine receptor-like protein; Provisional Back     alignment and domain information
>gnl|CDD|165177 PHA02834, PHA02834, chemokine receptor-like protein; Provisional Back     alignment and domain information

Conserved Domains Detected by HHsearch ?

ID ?Alignment Graph ?Length ? Definition ? Probability ?
Query 662
KOG4219|consensus423 100.0
KOG4220|consensus503 100.0
PHA03234338 DNA packaging protein UL33; Provisional 100.0
PHA03235409 DNA packaging protein UL33; Provisional 100.0
PHA02834323 chemokine receptor-like protein; Provisional 100.0
PHA02638417 CC chemokine receptor-like protein; Provisional 100.0
PHA03087335 G protein-coupled chemokine receptor-like protein; 100.0
PF00001257 7tm_1: 7 transmembrane receptor (rhodopsin family) 99.97
KOG4220|consensus503 99.94
KOG2087|consensus363 99.9
PF10320257 7TM_GPCR_Srsx: Serpentine type 7TM GPCR chemorecep 99.86
KOG4219|consensus423 99.84
PHA03234338 DNA packaging protein UL33; Provisional 99.84
PHA03235409 DNA packaging protein UL33; Provisional 99.83
PF10324318 7TM_GPCR_Srw: Serpentine type 7TM GPCR chemorecept 99.83
PHA02834323 chemokine receptor-like protein; Provisional 99.79
PHA02638417 CC chemokine receptor-like protein; Provisional 99.77
PF10328274 7TM_GPCR_Srx: Serpentine type 7TM GPCR chemorecept 99.73
PHA03087335 G protein-coupled chemokine receptor-like protein; 99.71
PF00001257 7tm_1: 7 transmembrane receptor (rhodopsin family) 99.68
PF05296303 TAS2R: Mammalian taste receptor protein (TAS2R); I 99.65
PF10323283 7TM_GPCR_Srv: Serpentine type 7TM GPCR chemorecept 99.58
PF05462303 Dicty_CAR: Slime mold cyclic AMP receptor 99.56
PF10321313 7TM_GPCR_Srt: Serpentine type 7TM GPCR chemorecept 99.51
PF03402265 V1R: Vomeronasal organ pheromone receptor family, 99.12
PF10317292 7TM_GPCR_Srd: Serpentine type 7TM GPCR chemorecept 99.11
KOG2087|consensus363 98.9
PF11710201 Git3: G protein-coupled glucose receptor regulatin 98.83
KOG4193|consensus610 98.68
PF10327303 7TM_GPCR_Sri: Serpentine type 7TM GPCR chemorecept 98.6
PF10292324 7TM_GPCR_Srab: Serpentine type 7TM GPCR receptor c 98.6
PF02118275 Srg: Srg family chemoreceptor; InterPro: IPR000609 98.55
PF02101405 Ocular_alb: Ocular albinism type 1 protein; InterP 98.53
PF10324318 7TM_GPCR_Srw: Serpentine type 7TM GPCR chemorecept 98.46
PF10326307 7TM_GPCR_Str: Serpentine type 7TM GPCR chemorecept 98.33
PF04789305 DUF621: Protein of unknown function (DUF621); Inte 98.23
KOG4564|consensus473 98.22
PF10318302 7TM_GPCR_Srh: Serpentine type 7TM GPCR chemorecept 98.21
PF10319310 7TM_GPCR_Srj: Serpentine type 7TM GPCR chemorecept 98.18
PF10316273 7TM_GPCR_Srbc: Serpentine type 7TM GPCR chemorecep 98.17
PF05296303 TAS2R: Mammalian taste receptor protein (TAS2R); I 98.01
PF00002242 7tm_2: 7 transmembrane receptor (Secretin family); 97.99
PF03125365 Sre: C. elegans Sre G protein-coupled chemorecepto 97.66
PF10321313 7TM_GPCR_Srt: Serpentine type 7TM GPCR chemorecept 97.6
PF02117328 7TM_GPCR_Sra: Serpentine type 7TM GPCR chemorecept 97.56
PF10323283 7TM_GPCR_Srv: Serpentine type 7TM GPCR chemorecept 97.46
PF10322307 7TM_GPCR_Sru: Serpentine type 7TM GPCR chemorecept 97.39
PF10320257 7TM_GPCR_Srsx: Serpentine type 7TM GPCR chemorecep 97.22
PF02076283 STE3: Pheromone A receptor; InterPro: IPR001499 G- 97.16
PF05462303 Dicty_CAR: Slime mold cyclic AMP receptor 97.04
PF01534328 Frizzled: Frizzled/Smoothened family membrane regi 96.7
PF10328274 7TM_GPCR_Srx: Serpentine type 7TM GPCR chemorecept 96.16
PF06681226 DUF1182: Protein of unknown function (DUF1182); In 96.06
PF1197076 Git3_C: G protein-coupled glucose receptor regulat 95.81
PF10327303 7TM_GPCR_Sri: Serpentine type 7TM GPCR chemorecept 95.58
PF1197076 Git3_C: G protein-coupled glucose receptor regulat 95.03
PF03402265 V1R: Vomeronasal organ pheromone receptor family, 94.3
PF02101405 Ocular_alb: Ocular albinism type 1 protein; InterP 94.16
PF02175236 7TM_GPCR_Srb: Serpentine type 7TM GPCR chemorecept 94.03
PF04789305 DUF621: Protein of unknown function (DUF621); Inte 92.83
PF03383153 Serpentine_r_xa: Caenorhabditis serpentine recepto 92.29
PF13853144 7tm_4: Olfactory receptor 89.41
PF10317292 7TM_GPCR_Srd: Serpentine type 7TM GPCR chemorecept 88.28
>KOG4219|consensus Back     alignment and domain information
Probab=100.00  E-value=1.8e-42  Score=326.80  Aligned_cols=293  Identities=26%  Similarity=0.446  Sum_probs=245.8

Q ss_pred             hHhHHhHHHHHHHHHHHHHHHHHHhhHhhhhheeccccccchhhHHHHHHHHHHHhhhhhcccHHHHHhhcccccccccc
Q psy5093          44 WLELAQQRTLLVSTLSLFSLVTVFGNALVMIAVVRERYLHTSTNYFIMSLALADCLVGLVVMPFSALYELLDHNWIFGLN  123 (662)
Q Consensus        44 ~~~~~~~~~i~~~~~~ii~i~gl~gN~~vi~~i~~~~~lr~~~~~ll~~Lai~Dll~~l~~~p~~~~~~~~~~~~~~~~~  123 (662)
                      +....+.+.+.+++++++.+++++||.+|++++..+|++|+.+|+|++|||+||++.+++..++.....+ ..+|.+|.+
T Consensus        28 f~lp~~~~~~wai~yg~l~~vAv~GN~iVlwIil~hrrMRtvtnyfL~NLAfADl~~s~Fn~~f~f~yal-~~~W~~G~f  106 (423)
T KOG4219|consen   28 FVLPAWQQALWAIAYGLLVFVAVVGNLIVLWIILAHRRMRTVTNYFLVNLAFADLSMSIFNTVFNFQYAL-HQEWYFGSF  106 (423)
T ss_pred             ccCCHHHHHHHHHHHHHHHHHHHhcCceEEEEEeehhehhhhHHHHHHHHHHHHHHHHHHhhHHHHHHHH-Hhccccccc
Confidence            4456667899999999999999999999999999999999999999999999999999999998777665 468999999


Q ss_pred             chhHHHHhhHHHHHHHHHHHHHHHHHHhhhhcCCCCCCccccchhhhHHHHHHHHHHHhhhhhHHHhhhccccCCC---C
Q psy5093         124 WCDSWRSLDVLFSTASILNLCVISLDRYWAITDPLTYPSRMSTRRAYIWIAIVWICSGGISFPAILWWRAVRNEEV---P  200 (662)
Q Consensus       124 ~C~~~~~~~~~~~~~s~~~l~~iaidRy~~I~~P~~y~~~~t~~~~~~~i~~~w~~s~~~~~~~~~~~~~~~~~~~---~  200 (662)
                      +|++..|+..+...+|++++++||+|||.||.+|++.  +.+++...++++++|++++++++|..+..........   .
T Consensus       107 ~C~f~nf~~itav~vSVfTlvAiA~DRy~AIi~Pl~~--r~s~r~sk~iIllIW~lA~l~a~P~~l~s~v~~~~~~d~~~  184 (423)
T KOG4219|consen  107 YCRFVNFFPITAVFVSVFTLVAIAIDRYMAIIHPLQP--RPSRRSSKIIILLIWALALLLALPQLLYSSVEELYLYDGES  184 (423)
T ss_pred             eeeeccccchhhhhHhHHHHHHHHHHHHHHHhhhccc--CCCCcceeehhHHHHHHHHHHhccceeeeeeEEeeccCCcc
Confidence            9999999999999999999999999999999999984  3899999999999999999999999987655533221   1


Q ss_pred             CCcc---------ccCC----CcchhhhhHHHHHHHHHHHHHHHHHHHHHHHHHHhhccccCCcccccCCCCCCccceee
Q psy5093         201 KNKC---------PFTD----SKGYLIFSSTISFYLPLLVMVFTYFKIYRAAVVQTKSLKVGTKQVMSGSTSGEKELTLR  267 (662)
Q Consensus       201 ~~~c---------~~~~----~~~~~~~~~~~~~~ip~~ii~~~y~~I~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~  267 (662)
                      ...|         ....    ...|.....++.+++|++++.++|..|.+++|..+.....                   
T Consensus       185 ~~~~~~~~pe~~~~~~~~~~~~~~y~~vl~~lqYflPliVl~~~Yt~iav~LW~~~~~gd~-------------------  245 (423)
T KOG4219|consen  185 RVVCVTAWPEHVCPTENESLLMQGYNYVLLFLQYFLPLIVLGLAYTVIAVTLWGRRIPGDQ-------------------  245 (423)
T ss_pred             eEEEEEecccccCCcchhhhhhcceeeeehhHHHHHHHHHHHHHHHHHHHHHHhccCccch-------------------
Confidence            1222         2111    2337888899999999999999999999999975421100                   


Q ss_pred             eccCCCCCCCCccCCCCCCccccccccccCCCccccccccccccccccccccccccchhhHHhhhhhHHHHHHHHHHHHh
Q psy5093         268 IHRGGTDHRHMTLHHTPSDDVEMDNVMSGHNGITRQVSNTRIIHKGHIVKNFSLSRKLSKFAKEKKAAKTLGIVMGVFIV  347 (662)
Q Consensus       268 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~i~~~f~i  347 (662)
                                                                           ..+..+..+..+|+.||++++++.|.+
T Consensus       246 -----------------------------------------------------~d~~~~~~kak~K~vkmliiVV~~Fai  272 (423)
T KOG4219|consen  246 -----------------------------------------------------QDRKHEQLKAKKKVVKMLIIVVVIFAI  272 (423)
T ss_pred             -----------------------------------------------------hchhhHHHHHHHHHHHHHHHHHHHHHH
Confidence                                                                 002223445788999999999999999


Q ss_pred             hhhhHHHHHHHHHhhccccCCCchhHHHHHHHHHHHHhhccccchhhhhcChhHHHHHHHhcccC
Q psy5093         348 CWLPFFVVNLLSAVCTKCFWSEQDEELISAVVTWLGWINSGMNPVIYACWSRDFRSKEKILNHKI  412 (662)
Q Consensus       348 ~~~P~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~ns~~nP~IY~~~~~~fR~~~~~l~~~~  412 (662)
                      ||+|+.+..++....++.. ........+....||+..|+++||+||++.|++||.++++.||.|
T Consensus       273 cWlPyh~y~il~~~~~~i~-~~k~i~~vyl~~~WLaMSst~yNPiIY~~lN~Rfr~gf~~~fr~c  336 (423)
T KOG4219|consen  273 CWLPYHIYFILNATNPEIN-RKKFIQQVYLAIYWLAMSSTCYNPIIYCFLNKRFRGGFRRAFRWC  336 (423)
T ss_pred             hccChhHHHHHHHhHHHHH-HHHHHHHHHHHHHHHHHHHhhhccHhhhhhHHHHHHHHhhhhhee
Confidence            9999999999987654422 344556678899999999999999999999999999999999775



>KOG4220|consensus Back     alignment and domain information
>PHA03234 DNA packaging protein UL33; Provisional Back     alignment and domain information
>PHA03235 DNA packaging protein UL33; Provisional Back     alignment and domain information
>PHA02834 chemokine receptor-like protein; Provisional Back     alignment and domain information
>PHA02638 CC chemokine receptor-like protein; Provisional Back     alignment and domain information
>PHA03087 G protein-coupled chemokine receptor-like protein; Provisional Back     alignment and domain information
>PF00001 7tm_1: 7 transmembrane receptor (rhodopsin family) Rhodopsin-like GPCR superfamily signature 5-hydroxytryptamine 7 receptor signature bradykinin receptor signature gastrin receptor signature melatonin receptor signature olfactory receptor signature; InterPro: IPR000276 G-protein-coupled receptors, GPCRs, constitute a vast protein family that encompasses a wide range of functions (including various autocrine, paracrine and endocrine processes) Back     alignment and domain information
>KOG4220|consensus Back     alignment and domain information
>KOG2087|consensus Back     alignment and domain information
>PF10320 7TM_GPCR_Srsx: Serpentine type 7TM GPCR chemoreceptor Srsx; InterPro: IPR019424 G-protein-coupled receptors, GPCRs, constitute a vast protein family that encompasses a wide range of functions (including various autocrine, paracrine and endocrine processes) Back     alignment and domain information
>KOG4219|consensus Back     alignment and domain information
>PHA03234 DNA packaging protein UL33; Provisional Back     alignment and domain information
>PHA03235 DNA packaging protein UL33; Provisional Back     alignment and domain information
>PF10324 7TM_GPCR_Srw: Serpentine type 7TM GPCR chemoreceptor Srw; InterPro: IPR019427 G-protein-coupled receptors, GPCRs, constitute a vast protein family that encompasses a wide range of functions (including various autocrine, paracrine and endocrine processes) Back     alignment and domain information
>PHA02834 chemokine receptor-like protein; Provisional Back     alignment and domain information
>PHA02638 CC chemokine receptor-like protein; Provisional Back     alignment and domain information
>PF10328 7TM_GPCR_Srx: Serpentine type 7TM GPCR chemoreceptor Srx; InterPro: IPR019430 G-protein-coupled receptors, GPCRs, constitute a vast protein family that encompasses a wide range of functions (including various autocrine, paracrine and endocrine processes) Back     alignment and domain information
>PHA03087 G protein-coupled chemokine receptor-like protein; Provisional Back     alignment and domain information
>PF00001 7tm_1: 7 transmembrane receptor (rhodopsin family) Rhodopsin-like GPCR superfamily signature 5-hydroxytryptamine 7 receptor signature bradykinin receptor signature gastrin receptor signature melatonin receptor signature olfactory receptor signature; InterPro: IPR000276 G-protein-coupled receptors, GPCRs, constitute a vast protein family that encompasses a wide range of functions (including various autocrine, paracrine and endocrine processes) Back     alignment and domain information
>PF05296 TAS2R: Mammalian taste receptor protein (TAS2R); InterPro: IPR007960 This family consists of several forms of mammalian taste receptor proteins (TAS2Rs) Back     alignment and domain information
>PF10323 7TM_GPCR_Srv: Serpentine type 7TM GPCR chemoreceptor Srv; InterPro: IPR019426 G-protein-coupled receptors, GPCRs, constitute a vast protein family that encompasses a wide range of functions (including various autocrine, paracrine and endocrine processes) Back     alignment and domain information
>PF05462 Dicty_CAR: Slime mold cyclic AMP receptor Back     alignment and domain information
>PF10321 7TM_GPCR_Srt: Serpentine type 7TM GPCR chemoreceptor Srt; InterPro: IPR019425 Chemoreception is mediated in Caenorhabditis elegans by members of the seven-transmembrane G-protein-coupled receptor class (7TM GPCRs) of proteins which are of the serpentine type [] Back     alignment and domain information
>PF03402 V1R: Vomeronasal organ pheromone receptor family, V1R; InterPro: IPR004072 G-protein-coupled receptors, GPCRs, constitute a vast protein family that encompasses a wide range of functions (including various autocrine, paracrine and endocrine processes) Back     alignment and domain information
>PF10317 7TM_GPCR_Srd: Serpentine type 7TM GPCR chemoreceptor Srd; InterPro: IPR019421 G-protein-coupled receptors, GPCRs, constitute a vast protein family that encompasses a wide range of functions (including various autocrine, paracrine and endocrine processes) Back     alignment and domain information
>KOG2087|consensus Back     alignment and domain information
>PF11710 Git3: G protein-coupled glucose receptor regulating Gpa2; InterPro: IPR023041 This entry contains a functionally uncharacterised region belonging to the Git3 G-protein coupled receptor Back     alignment and domain information
>KOG4193|consensus Back     alignment and domain information
>PF10327 7TM_GPCR_Sri: Serpentine type 7TM GPCR chemoreceptor Sri; InterPro: IPR019429 G-protein-coupled receptors, GPCRs, constitute a vast protein family that encompasses a wide range of functions (including various autocrine, paracrine and endocrine processes) Back     alignment and domain information
>PF10292 7TM_GPCR_Srab: Serpentine type 7TM GPCR receptor class ab chemoreceptor; InterPro: IPR019408 G-protein-coupled receptors, GPCRs, constitute a vast protein family that encompasses a wide range of functions (including various autocrine, paracrine and endocrine processes) Back     alignment and domain information
>PF02118 Srg: Srg family chemoreceptor; InterPro: IPR000609 G-protein-coupled receptors, GPCRs, constitute a vast protein family that encompasses a wide range of functions (including various autocrine, paracrine and endocrine processes) Back     alignment and domain information
>PF02101 Ocular_alb: Ocular albinism type 1 protein; InterPro: IPR001414 Ocular albinism type 1 (OA1) is an X-linked disorder characterised by severe impairment of visual acuity, retinal hypopigmentation and the presence of macromelanosomes Back     alignment and domain information
>PF10324 7TM_GPCR_Srw: Serpentine type 7TM GPCR chemoreceptor Srw; InterPro: IPR019427 G-protein-coupled receptors, GPCRs, constitute a vast protein family that encompasses a wide range of functions (including various autocrine, paracrine and endocrine processes) Back     alignment and domain information
>PF10326 7TM_GPCR_Str: Serpentine type 7TM GPCR chemoreceptor Str; InterPro: IPR019428 G-protein-coupled receptors, GPCRs, constitute a vast protein family that encompasses a wide range of functions (including various autocrine, paracrine and endocrine processes) Back     alignment and domain information
>PF04789 DUF621: Protein of unknown function (DUF621); InterPro: IPR006874 This is a conserved region found in uncharacterised proteins from Caenorhabditis elegans, and is noted to have possible G-protein-coupled receptor-like activity Back     alignment and domain information
>KOG4564|consensus Back     alignment and domain information
>PF10318 7TM_GPCR_Srh: Serpentine type 7TM GPCR chemoreceptor Srh; InterPro: IPR019422 G-protein-coupled receptors, GPCRs, constitute a vast protein family that encompasses a wide range of functions (including various autocrine, paracrine and endocrine processes) Back     alignment and domain information
>PF10319 7TM_GPCR_Srj: Serpentine type 7TM GPCR chemoreceptor Srj; InterPro: IPR019423 G-protein-coupled receptors, GPCRs, constitute a vast protein family that encompasses a wide range of functions (including various autocrine, paracrine and endocrine processes) Back     alignment and domain information
>PF10316 7TM_GPCR_Srbc: Serpentine type 7TM GPCR chemoreceptor Srbc ; InterPro: IPR019420 G-protein-coupled receptors, GPCRs, constitute a vast protein family that encompasses a wide range of functions (including various autocrine, paracrine and endocrine processes) Back     alignment and domain information
>PF05296 TAS2R: Mammalian taste receptor protein (TAS2R); InterPro: IPR007960 This family consists of several forms of mammalian taste receptor proteins (TAS2Rs) Back     alignment and domain information
>PF00002 7tm_2: 7 transmembrane receptor (Secretin family); InterPro: IPR000832 G-protein-coupled receptors, GPCRs, constitute a vast protein family that encompasses a wide range of functions (including various autocrine, paracrine and endocrine processes) Back     alignment and domain information
>PF03125 Sre: C Back     alignment and domain information
>PF10321 7TM_GPCR_Srt: Serpentine type 7TM GPCR chemoreceptor Srt; InterPro: IPR019425 Chemoreception is mediated in Caenorhabditis elegans by members of the seven-transmembrane G-protein-coupled receptor class (7TM GPCRs) of proteins which are of the serpentine type [] Back     alignment and domain information
>PF02117 7TM_GPCR_Sra: Serpentine type 7TM GPCR chemoreceptor Sra; InterPro: IPR000344 G-protein-coupled receptors, GPCRs, constitute a vast protein family that encompasses a wide range of functions (including various autocrine, paracrine and endocrine processes) Back     alignment and domain information
>PF10323 7TM_GPCR_Srv: Serpentine type 7TM GPCR chemoreceptor Srv; InterPro: IPR019426 G-protein-coupled receptors, GPCRs, constitute a vast protein family that encompasses a wide range of functions (including various autocrine, paracrine and endocrine processes) Back     alignment and domain information
>PF10322 7TM_GPCR_Sru: Serpentine type 7TM GPCR chemoreceptor Sru; InterPro: IPR003839 G-protein-coupled receptors, GPCRs, constitute a vast protein family that encompasses a wide range of functions (including various autocrine, paracrine and endocrine processes) Back     alignment and domain information
>PF10320 7TM_GPCR_Srsx: Serpentine type 7TM GPCR chemoreceptor Srsx; InterPro: IPR019424 G-protein-coupled receptors, GPCRs, constitute a vast protein family that encompasses a wide range of functions (including various autocrine, paracrine and endocrine processes) Back     alignment and domain information
>PF02076 STE3: Pheromone A receptor; InterPro: IPR001499 G-protein-coupled receptors, GPCRs, constitute a vast protein family that encompasses a wide range of functions (including various autocrine, paracrine and endocrine processes) Back     alignment and domain information
>PF05462 Dicty_CAR: Slime mold cyclic AMP receptor Back     alignment and domain information
>PF01534 Frizzled: Frizzled/Smoothened family membrane region; InterPro: IPR000539 The frizzled (fz) locus of Drosophila coordinates the cytoskeletons of epidermal cells, producing a parallel array of cuticular hairs and bristles [, ] Back     alignment and domain information
>PF10328 7TM_GPCR_Srx: Serpentine type 7TM GPCR chemoreceptor Srx; InterPro: IPR019430 G-protein-coupled receptors, GPCRs, constitute a vast protein family that encompasses a wide range of functions (including various autocrine, paracrine and endocrine processes) Back     alignment and domain information
>PF06681 DUF1182: Protein of unknown function (DUF1182); InterPro: IPR010601 This family consists of several hypothetical proteins of around 360 residues in length and seems to be specific to Caenorhabditis elegans Back     alignment and domain information
>PF11970 Git3_C: G protein-coupled glucose receptor regulating Gpa2 C-term; InterPro: IPR022596 This entry contains a functionally uncharacterised region belonging to the Git3 G-protein coupled receptor Back     alignment and domain information
>PF10327 7TM_GPCR_Sri: Serpentine type 7TM GPCR chemoreceptor Sri; InterPro: IPR019429 G-protein-coupled receptors, GPCRs, constitute a vast protein family that encompasses a wide range of functions (including various autocrine, paracrine and endocrine processes) Back     alignment and domain information
>PF11970 Git3_C: G protein-coupled glucose receptor regulating Gpa2 C-term; InterPro: IPR022596 This entry contains a functionally uncharacterised region belonging to the Git3 G-protein coupled receptor Back     alignment and domain information
>PF03402 V1R: Vomeronasal organ pheromone receptor family, V1R; InterPro: IPR004072 G-protein-coupled receptors, GPCRs, constitute a vast protein family that encompasses a wide range of functions (including various autocrine, paracrine and endocrine processes) Back     alignment and domain information
>PF02101 Ocular_alb: Ocular albinism type 1 protein; InterPro: IPR001414 Ocular albinism type 1 (OA1) is an X-linked disorder characterised by severe impairment of visual acuity, retinal hypopigmentation and the presence of macromelanosomes Back     alignment and domain information
>PF02175 7TM_GPCR_Srb: Serpentine type 7TM GPCR chemoreceptor Srb; InterPro: IPR002184 G-protein-coupled receptors, GPCRs, constitute a vast protein family that encompasses a wide range of functions (including various autocrine, paracrine and endocrine processes) Back     alignment and domain information
>PF04789 DUF621: Protein of unknown function (DUF621); InterPro: IPR006874 This is a conserved region found in uncharacterised proteins from Caenorhabditis elegans, and is noted to have possible G-protein-coupled receptor-like activity Back     alignment and domain information
>PF03383 Serpentine_r_xa: Caenorhabditis serpentine receptor-like protein, class xa; InterPro: IPR005047 G-protein-coupled receptors, GPCRs, constitute a vast protein family that encompasses a wide range of functions (including various autocrine, paracrine and endocrine processes) Back     alignment and domain information
>PF13853 7tm_4: Olfactory receptor Back     alignment and domain information
>PF10317 7TM_GPCR_Srd: Serpentine type 7TM GPCR chemoreceptor Srd; InterPro: IPR019421 G-protein-coupled receptors, GPCRs, constitute a vast protein family that encompasses a wide range of functions (including various autocrine, paracrine and endocrine processes) Back     alignment and domain information

Homologous Structure Templates

Structure Templates Detected by BLAST ?

ID ?Alignment Graph ?Length ? Definition ? E-value ?
Query662
3sn6_R514 Crystal Structure Of The Beta2 Adrenergic Receptor- 4e-53
3sn6_R514 Crystal Structure Of The Beta2 Adrenergic Receptor- 2e-21
3kj6_A366 Crystal Structure Of A Methylated Beta2 Adrenergic 2e-52
3kj6_A366 Crystal Structure Of A Methylated Beta2 Adrenergic 5e-21
2r4s_A342 Crystal Structure Of The Human Beta2 Adrenoceptor L 3e-52
2r4s_A342 Crystal Structure Of The Human Beta2 Adrenoceptor L 8e-21
2r4r_A365 Crystal Structure Of The Human Beta2 Adrenoceptor L 3e-52
2r4r_A365 Crystal Structure Of The Human Beta2 Adrenoceptor L 7e-21
4gbr_A309 N-terminal T4 Lysozyme Fusion Facilitates Crystalli 1e-36
4gbr_A309 N-terminal T4 Lysozyme Fusion Facilitates Crystalli 9e-14
4gbr_A309 N-terminal T4 Lysozyme Fusion Facilitates Crystalli 9e-14
3p0g_A501 Structure Of A Nanobody-Stabilized Active State Of 2e-36
3p0g_A501 Structure Of A Nanobody-Stabilized Active State Of 2e-13
3p0g_A501 Structure Of A Nanobody-Stabilized Active State Of 2e-13
2rh1_A500 High Resolution Crystal Structure Of Human B2-Adren 2e-36
2rh1_A500 High Resolution Crystal Structure Of Human B2-Adren 2e-13
2rh1_A500 High Resolution Crystal Structure Of Human B2-Adren 2e-13
3d4s_A490 Cholesterol Bound Form Of Human Beta2 Adrenergic Re 4e-36
3d4s_A490 Cholesterol Bound Form Of Human Beta2 Adrenergic Re 2e-13
3d4s_A490 Cholesterol Bound Form Of Human Beta2 Adrenergic Re 2e-13
3pds_A458 Irreversible Agonist-Beta2 Adrenoceptor Complex Len 7e-36
3pds_A458 Irreversible Agonist-Beta2 Adrenoceptor Complex Len 3e-13
3pds_A458 Irreversible Agonist-Beta2 Adrenoceptor Complex Len 3e-13
2vt4_A313 Turkey Beta1 Adrenergic Receptor With Stabilising M 7e-34
2vt4_A313 Turkey Beta1 Adrenergic Receptor With Stabilising M 3e-13
2vt4_A313 Turkey Beta1 Adrenergic Receptor With Stabilising M 3e-13
2y00_B315 Turkey Beta1 Adrenergic Receptor With Stabilising M 7e-34
2y00_B315 Turkey Beta1 Adrenergic Receptor With Stabilising M 6e-13
3uon_A467 Structure Of The Human M2 Muscarinic Acetylcholine 9e-28
3uon_A467 Structure Of The Human M2 Muscarinic Acetylcholine 1e-04
3pbl_A481 Structure Of The Human Dopamine D3 Receptor In Comp 2e-27
3pbl_A481 Structure Of The Human Dopamine D3 Receptor In Comp 2e-14
4daj_A479 Structure Of The M3 Muscarinic Acetylcholine Recept 3e-27
4daj_A479 Structure Of The M3 Muscarinic Acetylcholine Recept 3e-07
4daj_A479 Structure Of The M3 Muscarinic Acetylcholine Recept 1e-06
4eiy_A447 Crystal Structure Of The Chimeric Protein Of A2aar- 1e-26
4eiy_A447 Crystal Structure Of The Chimeric Protein Of A2aar- 4e-11
3rze_A452 Structure Of The Human Histamine H1 Receptor In Com 1e-22
3rze_A452 Structure Of The Human Histamine H1 Receptor In Com 7e-12
3rze_A452 Structure Of The Human Histamine H1 Receptor In Com 1e-11
2ydo_A325 Thermostabilised Human A2a Receptor With Adenosine 9e-18
2ydo_A325 Thermostabilised Human A2a Receptor With Adenosine 3e-07
3vg9_A326 Crystal Structure Of Human Adenosine A2a Receptor W 1e-17
3vg9_A326 Crystal Structure Of Human Adenosine A2a Receptor W 3e-07
3pwh_A329 Thermostabilised Adenosine A2a Receptor Length = 32 1e-17
3pwh_A329 Thermostabilised Adenosine A2a Receptor Length = 32 2e-06
3eml_A488 The 2.6 A Crystal Structure Of A Human A2a Adenosin 1e-13
3eml_A488 The 2.6 A Crystal Structure Of A Human A2a Adenosin 7e-07
2ziy_A372 Crystal Structure Of Squid Rhodopsin Length = 372 3e-13
2z73_A448 Crystal Structure Of Squid Rhodopsin Length = 448 4e-13
4djh_A480 Structure Of The Human Kappa Opioid Receptor In Com 2e-12
4dkl_A464 Crystal Structure Of The Mu-Opioid Receptor Bound T 5e-11
4ea3_B434 Structure Of The NOFQ OPIOID RECEPTOR IN COMPLEX WI 6e-11
4ej4_A461 Structure Of The Delta Opioid Receptor Bound To Nal 1e-10
2x72_A349 Crystal Structure Of The Constitutively Active E113 1e-08
3oax_A349 Crystal Structure Of Bovine Rhodopsin With Beta-Ion 1e-08
1jfp_A348 Structure Of Bovine Rhodopsin (Dark Adapted) Length 1e-08
2j4y_A349 Crystal Structure Of A Rhodopsin Stabilizing Mutant 1e-08
3c9m_A348 Structure Of A Mutant Bovine Rhodopsin In Hexagonal 1e-08
4a4m_A349 Crystal Structure Of The Light-Activated Constituti 2e-08
2ks9_A364 Solution Conformation Of Substance P In Water Compl 3e-07
4grv_A510 The Crystal Structure Of The Neurotensin Receptor N 3e-05
3v2w_A520 Crystal Structure Of A Lipid G Protein-Coupled Rece 9e-05
>pdb|3SN6|R Chain R, Crystal Structure Of The Beta2 Adrenergic Receptor-Gs Protein Complex Length = 514 Back     alignment and structure

Iteration: 1

Score = 206 bits (524), Expect = 4e-53, Method: Compositional matrix adjust. Identities = 128/342 (37%), Positives = 176/342 (51%), Gaps = 65/342 (19%) Query: 68 GNALVMIAVVRERYLHTSTNYFIMSLALADCLVGLVVMPFSALYELLDHNWIFGLNWCDS 127 GN LV+ A+ + L T TNYFI SLA AD ++GL V+PF A + +L W FG WC+ Sbjct: 199 GNVLVITAIAKFERLQTVTNYFITSLACADLVMGLAVVPFGAAH-ILTKTWTFGNFWCEF 257 Query: 128 WRSLDVLFSTASILNLCVISLDRYWAITDPLTYPSRMSTRRAYIWIAIVWICSGGISFPA 187 W S+DVL TASI LCVI++DRY+AIT P Y S ++ +A + I +VWI SG SF Sbjct: 258 WTSIDVLCVTASIETLCVIAVDRYFAITSPFKYQSLLTKNKARVIILMVWIVSGLTSFLP 317 Query: 188 IL--WWRAVRNEEV----PKNKCPFTDSKGYLIFSSTISFYLPLLVMVFTYFKIYRAAVV 241 I W+RA E + + C F ++ Y I SS +SFY+PL++MVF Y ++++ A Sbjct: 318 IQMHWYRATHQEAINCYAEETCCDFFTNQAYAIASSIVSFYVPLVIMVFVYSRVFQEAKR 377 Query: 242 QTKSLKVGTKQVMSGSTSGEKELTLRIHRGGTDHRHMTLHHTPSDDVEMDNVMSGHNGIT 301 Q + + D H VE D +GH Sbjct: 378 QLQKI---------------------------DKSEGRFHVQNLSQVEQDG-RTGHG--- 406 Query: 302 RQVSNTRIIHKGHIVKNFSLSRKLSKFA-KEKKAAKTLGIVMGVFIVCWLPFFVVNLLSA 360 R+ SKF KE KA KTLGI+MG F +CWLPFF+VN++ Sbjct: 407 --------------------LRRSSKFCLKEHKALKTLGIIMGTFTLCWLPFFIVNIVHV 446 Query: 361 VCTKCFWSEQDEELISAVVTWLGWINSGMNPVIYACWSRDFR 402 + E + ++ W+G++NSG NP+IY C S DFR Sbjct: 447 IQDNLIRKE-----VYILLNWIGYVNSGFNPLIY-CRSPDFR 482
>pdb|3SN6|R Chain R, Crystal Structure Of The Beta2 Adrenergic Receptor-Gs Protein Complex Length = 514 Back     alignment and structure
>pdb|3KJ6|A Chain A, Crystal Structure Of A Methylated Beta2 Adrenergic Receptor- Fab Complex Length = 366 Back     alignment and structure
>pdb|3KJ6|A Chain A, Crystal Structure Of A Methylated Beta2 Adrenergic Receptor- Fab Complex Length = 366 Back     alignment and structure
>pdb|2R4S|A Chain A, Crystal Structure Of The Human Beta2 Adrenoceptor Length = 342 Back     alignment and structure
>pdb|2R4S|A Chain A, Crystal Structure Of The Human Beta2 Adrenoceptor Length = 342 Back     alignment and structure
>pdb|2R4R|A Chain A, Crystal Structure Of The Human Beta2 Adrenoceptor Length = 365 Back     alignment and structure
>pdb|2R4R|A Chain A, Crystal Structure Of The Human Beta2 Adrenoceptor Length = 365 Back     alignment and structure
>pdb|4GBR|A Chain A, N-terminal T4 Lysozyme Fusion Facilitates Crystallization Of A G Protein Coupled Receptor Length = 309 Back     alignment and structure
>pdb|4GBR|A Chain A, N-terminal T4 Lysozyme Fusion Facilitates Crystallization Of A G Protein Coupled Receptor Length = 309 Back     alignment and structure
>pdb|4GBR|A Chain A, N-terminal T4 Lysozyme Fusion Facilitates Crystallization Of A G Protein Coupled Receptor Length = 309 Back     alignment and structure
>pdb|3P0G|A Chain A, Structure Of A Nanobody-Stabilized Active State Of The Beta2 Adrenoceptor Length = 501 Back     alignment and structure
>pdb|3P0G|A Chain A, Structure Of A Nanobody-Stabilized Active State Of The Beta2 Adrenoceptor Length = 501 Back     alignment and structure
>pdb|3P0G|A Chain A, Structure Of A Nanobody-Stabilized Active State Of The Beta2 Adrenoceptor Length = 501 Back     alignment and structure
>pdb|2RH1|A Chain A, High Resolution Crystal Structure Of Human B2-Adrenergic G Protein- Coupled Receptor Length = 500 Back     alignment and structure
>pdb|2RH1|A Chain A, High Resolution Crystal Structure Of Human B2-Adrenergic G Protein- Coupled Receptor Length = 500 Back     alignment and structure
>pdb|2RH1|A Chain A, High Resolution Crystal Structure Of Human B2-Adrenergic G Protein- Coupled Receptor Length = 500 Back     alignment and structure
>pdb|3D4S|A Chain A, Cholesterol Bound Form Of Human Beta2 Adrenergic Receptor. Length = 490 Back     alignment and structure
>pdb|3D4S|A Chain A, Cholesterol Bound Form Of Human Beta2 Adrenergic Receptor. Length = 490 Back     alignment and structure
>pdb|3D4S|A Chain A, Cholesterol Bound Form Of Human Beta2 Adrenergic Receptor. Length = 490 Back     alignment and structure
>pdb|3PDS|A Chain A, Irreversible Agonist-Beta2 Adrenoceptor Complex Length = 458 Back     alignment and structure
>pdb|3PDS|A Chain A, Irreversible Agonist-Beta2 Adrenoceptor Complex Length = 458 Back     alignment and structure
>pdb|3PDS|A Chain A, Irreversible Agonist-Beta2 Adrenoceptor Complex Length = 458 Back     alignment and structure
>pdb|2VT4|A Chain A, Turkey Beta1 Adrenergic Receptor With Stabilising Mutations And Bound Cyanopindolol Length = 313 Back     alignment and structure
>pdb|2VT4|A Chain A, Turkey Beta1 Adrenergic Receptor With Stabilising Mutations And Bound Cyanopindolol Length = 313 Back     alignment and structure
>pdb|2VT4|A Chain A, Turkey Beta1 Adrenergic Receptor With Stabilising Mutations And Bound Cyanopindolol Length = 313 Back     alignment and structure
>pdb|2Y00|B Chain B, Turkey Beta1 Adrenergic Receptor With Stabilising Mutations And Bound Partial Agonist Dobutamine (Crystal Dob92) Length = 315 Back     alignment and structure
>pdb|2Y00|B Chain B, Turkey Beta1 Adrenergic Receptor With Stabilising Mutations And Bound Partial Agonist Dobutamine (Crystal Dob92) Length = 315 Back     alignment and structure
>pdb|3UON|A Chain A, Structure Of The Human M2 Muscarinic Acetylcholine Receptor Bound To An Antagonist Length = 467 Back     alignment and structure
>pdb|3UON|A Chain A, Structure Of The Human M2 Muscarinic Acetylcholine Receptor Bound To An Antagonist Length = 467 Back     alignment and structure
>pdb|3PBL|A Chain A, Structure Of The Human Dopamine D3 Receptor In Complex With Eticlopride Length = 481 Back     alignment and structure
>pdb|3PBL|A Chain A, Structure Of The Human Dopamine D3 Receptor In Complex With Eticlopride Length = 481 Back     alignment and structure
>pdb|4DAJ|A Chain A, Structure Of The M3 Muscarinic Acetylcholine Receptor Length = 479 Back     alignment and structure
>pdb|4DAJ|A Chain A, Structure Of The M3 Muscarinic Acetylcholine Receptor Length = 479 Back     alignment and structure
>pdb|4DAJ|A Chain A, Structure Of The M3 Muscarinic Acetylcholine Receptor Length = 479 Back     alignment and structure
>pdb|4EIY|A Chain A, Crystal Structure Of The Chimeric Protein Of A2aar-Bril In Complex With Zm241385 At 1.8a Resolution Length = 447 Back     alignment and structure
>pdb|4EIY|A Chain A, Crystal Structure Of The Chimeric Protein Of A2aar-Bril In Complex With Zm241385 At 1.8a Resolution Length = 447 Back     alignment and structure
>pdb|3RZE|A Chain A, Structure Of The Human Histamine H1 Receptor In Complex With Doxepin Length = 452 Back     alignment and structure
>pdb|3RZE|A Chain A, Structure Of The Human Histamine H1 Receptor In Complex With Doxepin Length = 452 Back     alignment and structure
>pdb|3RZE|A Chain A, Structure Of The Human Histamine H1 Receptor In Complex With Doxepin Length = 452 Back     alignment and structure
>pdb|2YDO|A Chain A, Thermostabilised Human A2a Receptor With Adenosine Bound Length = 325 Back     alignment and structure
>pdb|2YDO|A Chain A, Thermostabilised Human A2a Receptor With Adenosine Bound Length = 325 Back     alignment and structure
>pdb|3VG9|A Chain A, Crystal Structure Of Human Adenosine A2a Receptor With An Allosteric Inverse-Agonist Antibody At 2.7 A Resolution Length = 326 Back     alignment and structure
>pdb|3VG9|A Chain A, Crystal Structure Of Human Adenosine A2a Receptor With An Allosteric Inverse-Agonist Antibody At 2.7 A Resolution Length = 326 Back     alignment and structure
>pdb|3PWH|A Chain A, Thermostabilised Adenosine A2a Receptor Length = 329 Back     alignment and structure
>pdb|3PWH|A Chain A, Thermostabilised Adenosine A2a Receptor Length = 329 Back     alignment and structure
>pdb|3EML|A Chain A, The 2.6 A Crystal Structure Of A Human A2a Adenosine Receptor Bound To Zm241385. Length = 488 Back     alignment and structure
>pdb|3EML|A Chain A, The 2.6 A Crystal Structure Of A Human A2a Adenosine Receptor Bound To Zm241385. Length = 488 Back     alignment and structure
>pdb|2ZIY|A Chain A, Crystal Structure Of Squid Rhodopsin Length = 372 Back     alignment and structure
>pdb|2Z73|A Chain A, Crystal Structure Of Squid Rhodopsin Length = 448 Back     alignment and structure
>pdb|4DJH|A Chain A, Structure Of The Human Kappa Opioid Receptor In Complex With Jdtic Length = 480 Back     alignment and structure
>pdb|4DKL|A Chain A, Crystal Structure Of The Mu-Opioid Receptor Bound To A Morphinan Antagonist Length = 464 Back     alignment and structure
>pdb|4EA3|B Chain B, Structure Of The NOFQ OPIOID RECEPTOR IN COMPLEX WITH A PEPTIDE Mimetic Length = 434 Back     alignment and structure
>pdb|4EJ4|A Chain A, Structure Of The Delta Opioid Receptor Bound To Naltrindole Length = 461 Back     alignment and structure
>pdb|2X72|A Chain A, Crystal Structure Of The Constitutively Active E113q,N2c, D282c Rhodopsin Mutant With Bound Galphact Peptide Length = 349 Back     alignment and structure
>pdb|3OAX|A Chain A, Crystal Structure Of Bovine Rhodopsin With Beta-Ionone Length = 349 Back     alignment and structure
>pdb|1JFP|A Chain A, Structure Of Bovine Rhodopsin (Dark Adapted) Length = 348 Back     alignment and structure
>pdb|2J4Y|A Chain A, Crystal Structure Of A Rhodopsin Stabilizing Mutant Expressed In Mammalian Cells Length = 349 Back     alignment and structure
>pdb|3C9M|A Chain A, Structure Of A Mutant Bovine Rhodopsin In Hexagonal Crystal Form Length = 348 Back     alignment and structure
>pdb|4A4M|A Chain A, Crystal Structure Of The Light-Activated Constitutively Active N2c,M257y,D282c Rhodopsin Mutant In Complex With A Peptide Resembling The C-Terminus Of The Galpha-Protein Subunit (Gact) Length = 349 Back     alignment and structure
>pdb|2KS9|A Chain A, Solution Conformation Of Substance P In Water Complexed With Nk1r Length = 364 Back     alignment and structure
>pdb|4GRV|A Chain A, The Crystal Structure Of The Neurotensin Receptor Nts1 In Complex With Neurotensin (8-13) Length = 510 Back     alignment and structure
>pdb|3V2W|A Chain A, Crystal Structure Of A Lipid G Protein-Coupled Receptor At 3.35a Length = 520 Back     alignment and structure

Structure Templates Detected by RPS-BLAST ?

ID ?Alignment Graph ?Length ? Definition ? E-value ?
Query662
4eiy_A447 Adenosine receptor A2A/soluble cytochrome B562 CH; 1e-112
4eiy_A447 Adenosine receptor A2A/soluble cytochrome B562 CH; 2e-37
3sn6_R514 Lysozyme, beta-2 adrenergic receptor; seven transm 1e-110
3sn6_R514 Lysozyme, beta-2 adrenergic receptor; seven transm 6e-36
2rh1_A500 Beta-2-adrenergic receptor/T4-lysozyme chimera; GP 4e-90
2rh1_A500 Beta-2-adrenergic receptor/T4-lysozyme chimera; GP 2e-21
2rh1_A500 Beta-2-adrenergic receptor/T4-lysozyme chimera; GP 5e-21
2rh1_A 500 Beta-2-adrenergic receptor/T4-lysozyme chimera; GP 1e-15
3uon_A467 Human M2 muscarinic acetylcholine, receptor T4 LY 2e-89
3uon_A467 Human M2 muscarinic acetylcholine, receptor T4 LY 1e-22
3uon_A467 Human M2 muscarinic acetylcholine, receptor T4 LY 3e-22
3uon_A467 Human M2 muscarinic acetylcholine, receptor T4 LY 4e-15
3rze_A452 Histamine H1 receptor, lysozyme chimera; structura 2e-87
3rze_A452 Histamine H1 receptor, lysozyme chimera; structura 2e-22
3rze_A452 Histamine H1 receptor, lysozyme chimera; structura 5e-22
3rze_A452 Histamine H1 receptor, lysozyme chimera; structura 1e-14
3pbl_A481 D(3) dopamine receptor, lysozyme chimera; structur 5e-87
3pbl_A481 D(3) dopamine receptor, lysozyme chimera; structur 3e-23
3pbl_A481 D(3) dopamine receptor, lysozyme chimera; structur 7e-23
3pbl_A481 D(3) dopamine receptor, lysozyme chimera; structur 1e-13
3eml_A488 Human adenosine A2A receptor/T4 lysozyme chimera; 7e-82
3eml_A488 Human adenosine A2A receptor/T4 lysozyme chimera; 1e-25
3eml_A488 Human adenosine A2A receptor/T4 lysozyme chimera; 3e-25
3eml_A 488 Human adenosine A2A receptor/T4 lysozyme chimera; 3e-11
4amj_A315 Beta-1 adrenergic receptor; membrane protein, 7TMR 1e-80
4amj_A315 Beta-1 adrenergic receptor; membrane protein, 7TMR 7e-20
4amj_A315 Beta-1 adrenergic receptor; membrane protein, 7TMR 2e-19
4amj_A315 Beta-1 adrenergic receptor; membrane protein, 7TMR 1e-11
3v2y_A520 Sphingosine 1-phosphate receptor 1, lysozyme CHIM; 8e-61
3v2y_A520 Sphingosine 1-phosphate receptor 1, lysozyme CHIM; 9e-23
3v2y_A520 Sphingosine 1-phosphate receptor 1, lysozyme CHIM; 3e-22
3v2y_A 520 Sphingosine 1-phosphate receptor 1, lysozyme CHIM; 4e-06
2ks9_A364 Substance-P receptor; water, autodock, NK1, neurop 4e-40
2ks9_A364 Substance-P receptor; water, autodock, NK1, neurop 2e-11
2ks9_A364 Substance-P receptor; water, autodock, NK1, neurop 3e-11
2z73_A448 Rhodopsin; visual pigment, GQ-type, G-protein coup 3e-37
2z73_A 448 Rhodopsin; visual pigment, GQ-type, G-protein coup 1e-08
2z73_A448 Rhodopsin; visual pigment, GQ-type, G-protein coup 2e-08
2z73_A448 Rhodopsin; visual pigment, GQ-type, G-protein coup 2e-04
1u19_A349 Rhodopsin; G protein-coupled receptor, membrane pr 5e-36
1u19_A349 Rhodopsin; G protein-coupled receptor, membrane pr 2e-06
1u19_A349 Rhodopsin; G protein-coupled receptor, membrane pr 4e-06
4dkl_A464 MU-type opioid receptor, lysozyme chimera; G-prote 2e-35
4dkl_A464 MU-type opioid receptor, lysozyme chimera; G-prote 4e-11
4dkl_A464 MU-type opioid receptor, lysozyme chimera; G-prote 9e-11
4ea3_A434 Fusion protein of nociceptin receptor and cytochr; 3e-34
4ea3_A434 Fusion protein of nociceptin receptor and cytochr; 1e-12
4ea3_A434 Fusion protein of nociceptin receptor and cytochr; 3e-12
3odu_A502 C-X-C chemokine receptor type 4, lysozyme chimera; 6e-33
3odu_A502 C-X-C chemokine receptor type 4, lysozyme chimera; 3e-06
3odu_A502 C-X-C chemokine receptor type 4, lysozyme chimera; 6e-06
1hll_A32 Alpha-2A adrenergic receptor; helix-linker-helix, 2e-14
1vt4_I 1221 APAF-1 related killer DARK; drosophila apoptosome, 2e-04
>4eiy_A Adenosine receptor A2A/soluble cytochrome B562 CH; novel protein engineering, GPCR network, PSI-biology, struct genomics, membrane protein, GPCR; HET: ZMA CLR OLA OLC OLB; 1.80A {Homo sapiens} PDB: 3vg9_A* 3vga_A* 2ydv_A* 2ydo_A* 3uza_A* 3rey_A* 3rfm_A* 3pwh_A* 3uzc_A* 4er9_A Length = 447 Back     alignment and structure
 Score =  344 bits (884), Expect = e-112
 Identities = 92/418 (22%), Positives = 154/418 (36%), Gaps = 47/418 (11%)

Query: 26  IDDDVVTYDFVSNFTLERWLELAQQRTLLVSTLSLFSLVTVFGNALVMIAVVRERYLHTS 85
               +    F      +         ++ ++     +++ + GN LV  AV     L   
Sbjct: 6   ALSYIFCLVFADYKDDDDGAPPIMGSSVYITVELAIAVLAILGNVLVCWAVWLNSNLQNV 65

Query: 86  TNYFIMSLALADCLVGLVVMPFSALYELLDHNWIFGLNWCDSWRSLDVLFSTASILNLCV 145
           TNYF++SLA AD  VG++ +PF+         +    + C       ++ + +SI +L  
Sbjct: 66  TNYFVVSLAAADIAVGVLAIPFAITIST---GFCAACHGCLFIACFVLVLTQSSIFSLLA 122

Query: 146 ISLDRYWAITDPLTYPSRMSTRRAYIWIAIVWICSGGISFPAILWWRAVRNEEVPKNKCP 205
           I++DRY AI  PL Y   ++  RA   IAI W+ S  I    +L W      +  KN   
Sbjct: 123 IAIDRYIAIRIPLRYNGLVTGTRAKGIIAICWVLSFAIGLTPMLGWNNCGQPKEGKNHSQ 182

Query: 206 -------------FTDSKGYLIFSSTISFYLPLLVMVFTYFKIYRAAVVQTKSLKVGTKQ 252
                               + F+      +PLL+M+  Y +I+ AA  Q   L+   + 
Sbjct: 183 GCGEGQVACLFEDVVPMNYMVYFNFFACVLVPLLLMLGVYLRIFLAARRQLADLEDNWET 242

Query: 253 VMSGSTSGEKELTLRIHRGGTDHRHMTL------------HHTPSDDVEMDNVMSGHNGI 300
           +       EK       +                        +P      D        +
Sbjct: 243 LNDNLKVIEKADNAAQVKDALTKMRAAALDAQKATPPKLEDKSPDSPEMKDFRHGFDILV 302

Query: 301 TRQVSNTRIIHKGHI----------------VKNFSLSRKLSKFAKEKKAAKTLGIVMGV 344
            +     ++ ++G +                     L R  S   KE  AAK+L I++G+
Sbjct: 303 GQIDDALKLANEGKVKEAQAAAEQLKTTRNAYIQKYLERARSTLQKEVHAAKSLAIIVGL 362

Query: 345 FIVCWLPFFVVNLLSAVCTKCFWSEQDEELISAVVTWLGWINSGMNPVIYACWSRDFR 402
           F +CWLP  ++N  +  C  C  +      +  +   L   NS +NP IYA   R+FR
Sbjct: 363 FALCWLPLHIINCFTFFCPDCSHA---PLWLMYLAIVLSHTNSVVNPFIYAYRIREFR 417


>4eiy_A Adenosine receptor A2A/soluble cytochrome B562 CH; novel protein engineering, GPCR network, PSI-biology, struct genomics, membrane protein, GPCR; HET: ZMA CLR OLA OLC OLB; 1.80A {Homo sapiens} PDB: 3vg9_A* 3vga_A* 2ydv_A* 2ydo_A* 3uza_A* 3rey_A* 3rfm_A* 3pwh_A* 3uzc_A* 4er9_A Length = 447 Back     alignment and structure
>3sn6_R Lysozyme, beta-2 adrenergic receptor; seven transmembrane receptor, nanobody, G protein-coupled RE GPCR, signal transduction, G protein signaling; HET: P0G; 3.20A {Enterobacteria phage T4} PDB: 3kj6_A 2r4s_A 2r4r_A Length = 514 Back     alignment and structure
>3sn6_R Lysozyme, beta-2 adrenergic receptor; seven transmembrane receptor, nanobody, G protein-coupled RE GPCR, signal transduction, G protein signaling; HET: P0G; 3.20A {Enterobacteria phage T4} PDB: 3kj6_A 2r4s_A 2r4r_A Length = 514 Back     alignment and structure
>2rh1_A Beta-2-adrenergic receptor/T4-lysozyme chimera; GPCR, 7TM, fusion, lipidic cubic phase, lipidic, mesophase, cholesterol, membrane protein; HET: MAL CAU CLR PLM 12P; 2.40A {Homo sapiens} PDB: 3p0g_A* 3d4s_A* 3ny8_A* 3ny9_A* 3nya_A* 3pds_A* Length = 500 Back     alignment and structure
>2rh1_A Beta-2-adrenergic receptor/T4-lysozyme chimera; GPCR, 7TM, fusion, lipidic cubic phase, lipidic, mesophase, cholesterol, membrane protein; HET: MAL CAU CLR PLM 12P; 2.40A {Homo sapiens} PDB: 3p0g_A* 3d4s_A* 3ny8_A* 3ny9_A* 3nya_A* 3pds_A* Length = 500 Back     alignment and structure
>2rh1_A Beta-2-adrenergic receptor/T4-lysozyme chimera; GPCR, 7TM, fusion, lipidic cubic phase, lipidic, mesophase, cholesterol, membrane protein; HET: MAL CAU CLR PLM 12P; 2.40A {Homo sapiens} PDB: 3p0g_A* 3d4s_A* 3ny8_A* 3ny9_A* 3nya_A* 3pds_A* Length = 500 Back     alignment and structure
>2rh1_A Beta-2-adrenergic receptor/T4-lysozyme chimera; GPCR, 7TM, fusion, lipidic cubic phase, lipidic, mesophase, cholesterol, membrane protein; HET: MAL CAU CLR PLM 12P; 2.40A {Homo sapiens} PDB: 3p0g_A* 3d4s_A* 3ny8_A* 3ny9_A* 3nya_A* 3pds_A* Length = 500 Back     alignment and structure
>3uon_A Human M2 muscarinic acetylcholine, receptor T4 LY fusion protein; G protein-coupled receptor, GPCR, SI protein-antagonist complex; HET: QNB BGC; 3.00A {Homo sapiens} PDB: 4daj_A* Length = 467 Back     alignment and structure
>3uon_A Human M2 muscarinic acetylcholine, receptor T4 LY fusion protein; G protein-coupled receptor, GPCR, SI protein-antagonist complex; HET: QNB BGC; 3.00A {Homo sapiens} PDB: 4daj_A* Length = 467 Back     alignment and structure
>3uon_A Human M2 muscarinic acetylcholine, receptor T4 LY fusion protein; G protein-coupled receptor, GPCR, SI protein-antagonist complex; HET: QNB BGC; 3.00A {Homo sapiens} PDB: 4daj_A* Length = 467 Back     alignment and structure
>3uon_A Human M2 muscarinic acetylcholine, receptor T4 LY fusion protein; G protein-coupled receptor, GPCR, SI protein-antagonist complex; HET: QNB BGC; 3.00A {Homo sapiens} PDB: 4daj_A* Length = 467 Back     alignment and structure
>3rze_A Histamine H1 receptor, lysozyme chimera; structural genomics, PSI-biology, membrane protein, GPCR NET GPCR, hydrolase; HET: 5EH D7V OLC; 3.10A {Homo sapiens} Length = 452 Back     alignment and structure
>3rze_A Histamine H1 receptor, lysozyme chimera; structural genomics, PSI-biology, membrane protein, GPCR NET GPCR, hydrolase; HET: 5EH D7V OLC; 3.10A {Homo sapiens} Length = 452 Back     alignment and structure
>3rze_A Histamine H1 receptor, lysozyme chimera; structural genomics, PSI-biology, membrane protein, GPCR NET GPCR, hydrolase; HET: 5EH D7V OLC; 3.10A {Homo sapiens} Length = 452 Back     alignment and structure
>3rze_A Histamine H1 receptor, lysozyme chimera; structural genomics, PSI-biology, membrane protein, GPCR NET GPCR, hydrolase; HET: 5EH D7V OLC; 3.10A {Homo sapiens} Length = 452 Back     alignment and structure
>3pbl_A D(3) dopamine receptor, lysozyme chimera; structural genomics, PSI-2, protein structure initiative, AC technologies center for gene to 3D structure; HET: ETQ MAL; 2.89A {Homo sapiens} Length = 481 Back     alignment and structure
>3pbl_A D(3) dopamine receptor, lysozyme chimera; structural genomics, PSI-2, protein structure initiative, AC technologies center for gene to 3D structure; HET: ETQ MAL; 2.89A {Homo sapiens} Length = 481 Back     alignment and structure
>3pbl_A D(3) dopamine receptor, lysozyme chimera; structural genomics, PSI-2, protein structure initiative, AC technologies center for gene to 3D structure; HET: ETQ MAL; 2.89A {Homo sapiens} Length = 481 Back     alignment and structure
>3pbl_A D(3) dopamine receptor, lysozyme chimera; structural genomics, PSI-2, protein structure initiative, AC technologies center for gene to 3D structure; HET: ETQ MAL; 2.89A {Homo sapiens} Length = 481 Back     alignment and structure
>3eml_A Human adenosine A2A receptor/T4 lysozyme chimera; caffeine, GPCR, membrane protein, LCP, mesophase, structural genomics, PSI-2; HET: ZMA STE; 2.60A {Homo sapiens} PDB: 3qak_A* Length = 488 Back     alignment and structure
>3eml_A Human adenosine A2A receptor/T4 lysozyme chimera; caffeine, GPCR, membrane protein, LCP, mesophase, structural genomics, PSI-2; HET: ZMA STE; 2.60A {Homo sapiens} PDB: 3qak_A* Length = 488 Back     alignment and structure
>3eml_A Human adenosine A2A receptor/T4 lysozyme chimera; caffeine, GPCR, membrane protein, LCP, mesophase, structural genomics, PSI-2; HET: ZMA STE; 2.60A {Homo sapiens} PDB: 3qak_A* Length = 488 Back     alignment and structure
>3eml_A Human adenosine A2A receptor/T4 lysozyme chimera; caffeine, GPCR, membrane protein, LCP, mesophase, structural genomics, PSI-2; HET: ZMA STE; 2.60A {Homo sapiens} PDB: 3qak_A* Length = 488 Back     alignment and structure
>4amj_A Beta-1 adrenergic receptor; membrane protein, 7TMR BETA1-adrenoceptor, stabilising mutat biased agonist; HET: CVD 2CV; 2.30A {Meleagris gallopavo} PDB: 2y01_A* 2y02_A* 2y03_A* 2y04_A* 4ami_A* 2y00_A* 2vt4_A* 2ycw_A* 2ycx_A* 2ycy_A* 2ycz_A* Length = 315 Back     alignment and structure
>4amj_A Beta-1 adrenergic receptor; membrane protein, 7TMR BETA1-adrenoceptor, stabilising mutat biased agonist; HET: CVD 2CV; 2.30A {Meleagris gallopavo} PDB: 2y01_A* 2y02_A* 2y03_A* 2y04_A* 4ami_A* 2y00_A* 2vt4_A* 2ycw_A* 2ycx_A* 2ycy_A* 2ycz_A* Length = 315 Back     alignment and structure
>4amj_A Beta-1 adrenergic receptor; membrane protein, 7TMR BETA1-adrenoceptor, stabilising mutat biased agonist; HET: CVD 2CV; 2.30A {Meleagris gallopavo} PDB: 2y01_A* 2y02_A* 2y03_A* 2y04_A* 4ami_A* 2y00_A* 2vt4_A* 2ycw_A* 2ycx_A* 2ycy_A* 2ycz_A* Length = 315 Back     alignment and structure
>4amj_A Beta-1 adrenergic receptor; membrane protein, 7TMR BETA1-adrenoceptor, stabilising mutat biased agonist; HET: CVD 2CV; 2.30A {Meleagris gallopavo} PDB: 2y01_A* 2y02_A* 2y03_A* 2y04_A* 4ami_A* 2y00_A* 2vt4_A* 2ycw_A* 2ycx_A* 2ycy_A* 2ycz_A* Length = 315 Back     alignment and structure
>3v2y_A Sphingosine 1-phosphate receptor 1, lysozyme CHIM; EDG receptor, lipid receptor, multiple sclerosi autoimmunity, structural genomics, PSI-biology; HET: ML5 NAG; 2.80A {Homo sapiens} PDB: 3v2w_A* Length = 520 Back     alignment and structure
>3v2y_A Sphingosine 1-phosphate receptor 1, lysozyme CHIM; EDG receptor, lipid receptor, multiple sclerosi autoimmunity, structural genomics, PSI-biology; HET: ML5 NAG; 2.80A {Homo sapiens} PDB: 3v2w_A* Length = 520 Back     alignment and structure
>3v2y_A Sphingosine 1-phosphate receptor 1, lysozyme CHIM; EDG receptor, lipid receptor, multiple sclerosi autoimmunity, structural genomics, PSI-biology; HET: ML5 NAG; 2.80A {Homo sapiens} PDB: 3v2w_A* Length = 520 Back     alignment and structure
>3v2y_A Sphingosine 1-phosphate receptor 1, lysozyme CHIM; EDG receptor, lipid receptor, multiple sclerosi autoimmunity, structural genomics, PSI-biology; HET: ML5 NAG; 2.80A {Homo sapiens} PDB: 3v2w_A* Length = 520 Back     alignment and structure
>2ks9_A Substance-P receptor; water, autodock, NK1, neuropeptide receptor-NEU complex; NMR {Homo sapiens} PDB: 2ksa_A 2ksb_A Length = 364 Back     alignment and structure
>2ks9_A Substance-P receptor; water, autodock, NK1, neuropeptide receptor-NEU complex; NMR {Homo sapiens} PDB: 2ksa_A 2ksb_A Length = 364 Back     alignment and structure
>2ks9_A Substance-P receptor; water, autodock, NK1, neuropeptide receptor-NEU complex; NMR {Homo sapiens} PDB: 2ksa_A 2ksb_A Length = 364 Back     alignment and structure
>2z73_A Rhodopsin; visual pigment, GQ-type, G-protein coupled receptor, chromophore, glycoprotein, lipoprotein, membrane, palmitate phosphorylation; HET: BOG RET PLM TWT PC1; 2.50A {Todarodes pacificus} PDB: 3aym_A* 3ayn_A* 2ziy_A* Length = 448 Back     alignment and structure
>2z73_A Rhodopsin; visual pigment, GQ-type, G-protein coupled receptor, chromophore, glycoprotein, lipoprotein, membrane, palmitate phosphorylation; HET: BOG RET PLM TWT PC1; 2.50A {Todarodes pacificus} PDB: 3aym_A* 3ayn_A* 2ziy_A* Length = 448 Back     alignment and structure
>2z73_A Rhodopsin; visual pigment, GQ-type, G-protein coupled receptor, chromophore, glycoprotein, lipoprotein, membrane, palmitate phosphorylation; HET: BOG RET PLM TWT PC1; 2.50A {Todarodes pacificus} PDB: 3aym_A* 3ayn_A* 2ziy_A* Length = 448 Back     alignment and structure
>2z73_A Rhodopsin; visual pigment, GQ-type, G-protein coupled receptor, chromophore, glycoprotein, lipoprotein, membrane, palmitate phosphorylation; HET: BOG RET PLM TWT PC1; 2.50A {Todarodes pacificus} PDB: 3aym_A* 3ayn_A* 2ziy_A* Length = 448 Back     alignment and structure
>1u19_A Rhodopsin; G protein-coupled receptor, membrane protein, retinal protei photoreceptor, signaling protein; HET: MAN NAG BMA RET PLM HTO HTG; 2.20A {Bos taurus} SCOP: f.13.1.2 PDB: 1hzx_A* 1gzm_A* 1l9h_A* 2g87_A* 2hpy_A* 2i35_A* 2i36_A* 2i37_A* 2ped_A* 3oax_A* 3c9l_A* 1jfp_A* 1ln6_A* 1f88_A* 3cap_A* 3dqb_A* 3pqr_A* 3pxo_A* 3c9m_A* 2x72_A* ... Length = 349 Back     alignment and structure
>1u19_A Rhodopsin; G protein-coupled receptor, membrane protein, retinal protei photoreceptor, signaling protein; HET: MAN NAG BMA RET PLM HTO HTG; 2.20A {Bos taurus} SCOP: f.13.1.2 PDB: 1hzx_A* 1gzm_A* 1l9h_A* 2g87_A* 2hpy_A* 2i35_A* 2i36_A* 2i37_A* 2ped_A* 3oax_A* 3c9l_A* 1jfp_A* 1ln6_A* 1f88_A* 3cap_A* 3dqb_A* 3pqr_A* 3pxo_A* 3c9m_A* 2x72_A* ... Length = 349 Back     alignment and structure
>1u19_A Rhodopsin; G protein-coupled receptor, membrane protein, retinal protei photoreceptor, signaling protein; HET: MAN NAG BMA RET PLM HTO HTG; 2.20A {Bos taurus} SCOP: f.13.1.2 PDB: 1hzx_A* 1gzm_A* 1l9h_A* 2g87_A* 2hpy_A* 2i35_A* 2i36_A* 2i37_A* 2ped_A* 3oax_A* 3c9l_A* 1jfp_A* 1ln6_A* 1f88_A* 3cap_A* 3dqb_A* 3pqr_A* 3pxo_A* 3c9m_A* 2x72_A* ... Length = 349 Back     alignment and structure
>4dkl_A MU-type opioid receptor, lysozyme chimera; G-protein coupled receptor, 7 transmembrane receptor, signal protein-antagonist complex; HET: BF0 CLR MPG 1PE; 2.80A {Mus musculus} PDB: 4ej4_A* 4djh_A* Length = 464 Back     alignment and structure
>4dkl_A MU-type opioid receptor, lysozyme chimera; G-protein coupled receptor, 7 transmembrane receptor, signal protein-antagonist complex; HET: BF0 CLR MPG 1PE; 2.80A {Mus musculus} PDB: 4ej4_A* 4djh_A* Length = 464 Back     alignment and structure
>4dkl_A MU-type opioid receptor, lysozyme chimera; G-protein coupled receptor, 7 transmembrane receptor, signal protein-antagonist complex; HET: BF0 CLR MPG 1PE; 2.80A {Mus musculus} PDB: 4ej4_A* 4djh_A* Length = 464 Back     alignment and structure
>3odu_A C-X-C chemokine receptor type 4, lysozyme chimera; structural genomics, PSI-2, protein structure initiative; HET: ITD OLC OLA; 2.50A {Homo sapiens} PDB: 3oe8_A* 3oe6_A* 3oe0_A* 3oe9_A* 2k03_B* 2k04_B 2k05_B* Length = 502 Back     alignment and structure
>3odu_A C-X-C chemokine receptor type 4, lysozyme chimera; structural genomics, PSI-2, protein structure initiative; HET: ITD OLC OLA; 2.50A {Homo sapiens} PDB: 3oe8_A* 3oe6_A* 3oe0_A* 3oe9_A* 2k03_B* 2k04_B 2k05_B* Length = 502 Back     alignment and structure
>3odu_A C-X-C chemokine receptor type 4, lysozyme chimera; structural genomics, PSI-2, protein structure initiative; HET: ITD OLC OLA; 2.50A {Homo sapiens} PDB: 3oe8_A* 3oe6_A* 3oe0_A* 3oe9_A* 2k03_B* 2k04_B 2k05_B* Length = 502 Back     alignment and structure
>1hll_A Alpha-2A adrenergic receptor; helix-linker-helix, membrane protein; NMR {Synthetic} SCOP: j.94.1.1 PDB: 1hof_A 1ho9_A 1hod_A Length = 32 Back     alignment and structure
>1vt4_I APAF-1 related killer DARK; drosophila apoptosome, apoptosis, programmed cell death; HET: DTP; 6.90A {Drosophila melanogaster} PDB: 3iz8_A* Length = 1221 Back     alignment and structure

Structure Templates Detected by HHsearch ?

ID ?Alignment Graph ?Length ? Definition ? Probability ?
Query662
4grv_A510 Neurotensin receptor type 1, lysozyme chimera; G-p 100.0
3vw7_A484 Proteinase-activated receptor 1, lysozyme; high re 100.0
2rh1_A500 Beta-2-adrenergic receptor/T4-lysozyme chimera; GP 100.0
3uon_A467 Human M2 muscarinic acetylcholine, receptor T4 LY 100.0
3odu_A502 C-X-C chemokine receptor type 4, lysozyme chimera; 100.0
3pbl_A481 D(3) dopamine receptor, lysozyme chimera; structur 100.0
3rze_A452 Histamine H1 receptor, lysozyme chimera; structura 100.0
3eml_A488 Human adenosine A2A receptor/T4 lysozyme chimera; 100.0
3v2y_A520 Sphingosine 1-phosphate receptor 1, lysozyme CHIM; 100.0
4dkl_A464 MU-type opioid receptor, lysozyme chimera; G-prote 100.0
2ks9_A364 Substance-P receptor; water, autodock, NK1, neurop 100.0
2lnl_A296 C-X-C chemokine receptor type 1; G protein coupled 100.0
2z73_A448 Rhodopsin; visual pigment, GQ-type, G-protein coup 100.0
4ea3_A434 Fusion protein of nociceptin receptor and cytochr; 100.0
1u19_A349 Rhodopsin; G protein-coupled receptor, membrane pr 100.0
4eiy_A447 Adenosine receptor A2A/soluble cytochrome B562 CH; 100.0
4amj_A315 Beta-1 adrenergic receptor; membrane protein, 7TMR 100.0
3sn6_R514 Lysozyme, beta-2 adrenergic receptor; seven transm 100.0
4grv_A510 Neurotensin receptor type 1, lysozyme chimera; G-p 99.93
3vw7_A484 Proteinase-activated receptor 1, lysozyme; high re 99.88
2rh1_A500 Beta-2-adrenergic receptor/T4-lysozyme chimera; GP 99.87
3uon_A467 Human M2 muscarinic acetylcholine, receptor T4 LY 99.85
3v2y_A520 Sphingosine 1-phosphate receptor 1, lysozyme CHIM; 99.85
3odu_A502 C-X-C chemokine receptor type 4, lysozyme chimera; 99.84
3rze_A452 Histamine H1 receptor, lysozyme chimera; structura 99.84
3eml_A488 Human adenosine A2A receptor/T4 lysozyme chimera; 99.83
4dkl_A464 MU-type opioid receptor, lysozyme chimera; G-prote 99.83
3pbl_A481 D(3) dopamine receptor, lysozyme chimera; structur 99.83
2z73_A 448 Rhodopsin; visual pigment, GQ-type, G-protein coup 99.81
4eiy_A447 Adenosine receptor A2A/soluble cytochrome B562 CH; 99.81
3sn6_R514 Lysozyme, beta-2 adrenergic receptor; seven transm 99.8
2lnl_A296 C-X-C chemokine receptor type 1; G protein coupled 99.8
2ks9_A364 Substance-P receptor; water, autodock, NK1, neurop 99.8
4amj_A315 Beta-1 adrenergic receptor; membrane protein, 7TMR 99.79
1u19_A349 Rhodopsin; G protein-coupled receptor, membrane pr 99.79
4ea3_A434 Fusion protein of nociceptin receptor and cytochr; 99.77
2koe_A40 Human cannabinoid receptor 1 - helix 7/8 peptide; 98.5
2koe_A40 Human cannabinoid receptor 1 - helix 7/8 peptide; 98.3
2ki9_A33 Cannabinoid receptor 2; GPCR, G-protein coupled re 98.29
1hll_A32 Alpha-2A adrenergic receptor; helix-linker-helix, 98.14
2ki9_A33 Cannabinoid receptor 2; GPCR, G-protein coupled re 97.56
2lot_A64 Apelin receptor; membrane protein; NMR {Homo sapie 96.11
2ket_A27 Cathelicidin-6; antimicrobial peptide, antibiotic, 81.11
>4grv_A Neurotensin receptor type 1, lysozyme chimera; G-protein coupled receptor, G-protein, signaling protein-agonist complex; HET: EPE; 2.80A {Rattus norvegicus} Back     alignment and structure
Probab=100.00  E-value=2.1e-46  Score=401.68  Aligned_cols=364  Identities=19%  Similarity=0.278  Sum_probs=236.1

Q ss_pred             hHHHHHHHHHHHHHHHHHHhhHhhhhheecccccc---chhhHHHHHHHHHHHhhhhhcccHHHHHhhc-cccccccccc
Q psy5093          49 QQRTLLVSTLSLFSLVTVFGNALVMIAVVRERYLH---TSTNYFIMSLALADCLVGLVVMPFSALYELL-DHNWIFGLNW  124 (662)
Q Consensus        49 ~~~~i~~~~~~ii~i~gl~gN~~vi~~i~~~~~lr---~~~~~ll~~Lai~Dll~~l~~~p~~~~~~~~-~~~~~~~~~~  124 (662)
                      ..++++.++|.+++++|++||+++++++.++|++|   +++|+|++|||++|++.+++.+|+.+...+. .+.|.+|+.+
T Consensus        30 ~~~v~~~~~~~~i~~~g~~gN~lvi~~i~~~~~~r~~~~~~n~~i~~La~aDll~~~~~~p~~~~~~~~~~~~w~~g~~~  109 (510)
T 4grv_A           30 YSKVLVTAIYLALFVVGTVGNSVTLFTLARKKSLQSLQSTVHYHLGSLALSDLLILLLAMPVELYNFIWVHHPWAFGDAG  109 (510)
T ss_dssp             HHHHHHHHHHHHHHHHHHHHHHHHHHHTSCC----CCHHHHHHHHHHHHHHHHHHHHHHHHHHHHHTTTCCSSCSSHHHH
T ss_pred             HHHHHHHHHHHHHHHHHHHHHHHhhhheeeecCCCCCCChHHHHHHHHHHHHHHHHHHHHHHHHHHHHHhCCCEEhhHHH
Confidence            34678888999999999999999999999887554   7889999999999999999999987776553 4679999999


Q ss_pred             hhHHHHhhHHHHHHHHHHHHHHHHHHhhhhcCCCCCCccccchhhhHHHHHHHHHHHhhhhhHHHhhhccccCCCC----
Q psy5093         125 CDSWRSLDVLFSTASILNLCVISLDRYWAITDPLTYPSRMSTRRAYIWIAIVWICSGGISFPAILWWRAVRNEEVP----  200 (662)
Q Consensus       125 C~~~~~~~~~~~~~s~~~l~~iaidRy~~I~~P~~y~~~~t~~~~~~~i~~~w~~s~~~~~~~~~~~~~~~~~~~~----  200 (662)
                      |++..++..++..+|++++++||+|||++|++|++|+..++++++..+++++|++++++++|+++.+.........    
T Consensus       110 C~~~~~~~~~~~~~S~~~l~~is~dRy~ai~~P~~~~~~~t~~~~~~~i~~~W~~s~~~~~p~~~~~~~~~~~~~~~~~~  189 (510)
T 4grv_A          110 CRGYYFLRDACTYATALNVASLSVARYLAICHPFKAKTLMSRSRTKKFISAIWLASALLAIPMLFTMGLQNRSADGTHPG  189 (510)
T ss_dssp             HHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHSCCCCCCCCCCSCCHHHHHHHHHHHHHHHTTHHHHEEEEECSSSSCCGG
T ss_pred             HHHHHHHHHHHHHHHHHHHHHHHHHheEEEeccccccccccccccceeehHHHHHHHHHHHHHHHhhcccccccCCCCCC
Confidence            9999999999999999999999999999999999999999999999999999999999999999987655433222    


Q ss_pred             CCccccCCC----cchhhhhHHHHHHHHHHHHHHHHHHHHHHHHHHhhccccCCcccc-----cCCCCCCccc-------
Q psy5093         201 KNKCPFTDS----KGYLIFSSTISFYLPLLVMVFTYFKIYRAAVVQTKSLKVGTKQVM-----SGSTSGEKEL-------  264 (662)
Q Consensus       201 ~~~c~~~~~----~~~~~~~~~~~~~ip~~ii~~~y~~I~~~l~~~~~~~~~~~~~~~-----~~~~~~~~~~-------  264 (662)
                      ...|.....    ..|..+..++.|++|+++++++|.+|++.++++.+.....+....     ..........       
T Consensus       190 ~~~c~~~~~~~~~~~~~~~~~~~~f~iP~~ii~~~Y~~I~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  269 (510)
T 4grv_A          190 GLVCTPIVDTATVKVVIQVNTFMSFLFPMLVISILNTVIANKLTVMVNIFEMLRIDEGLRLKIYKDTEGYYTIGIGHLLT  269 (510)
T ss_dssp             GEEEEECSCHHHHHHHHHHHHHHHTHHHHHHHHHHHHHHHHHHHTSCTHHHHHHHHTCCEEEEEECTTSCEEEETTEECC
T ss_pred             ccccccccccchhhhhhhhhhhHHHhhhHHHHHHHHHHHHHHHHHHhhhhhhhccccccccccccccccccccccccccC
Confidence            223433332    235556677889999999999999999999875443221110000     0000000000       


Q ss_pred             ---eeeeccCCCCCCCCccCCCCCCcccccc------------ccc---------cCC----------------------
Q psy5093         265 ---TLRIHRGGTDHRHMTLHHTPSDDVEMDN------------VMS---------GHN----------------------  298 (662)
Q Consensus       265 ---~~~~~~~~~~~~~~~~~~~~~~~~~~~~------------~~~---------~~~----------------------  298 (662)
                         .........+..............+.+.            ...         ...                      
T Consensus       270 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  349 (510)
T 4grv_A          270 KSPSLNAAKSELDKAIGRNTNGVITKDEAEKLFNQDVDAAVRGILRNAKLKPVYDSLDAVRRAALINMVFQMGETGVAGF  349 (510)
T ss_dssp             CSSSHHHHHHSCCC---CCCTTBCCHHHHHHHHHHHHHHHHHHHHHCTTTHHHHHHSCSHHHHHHHHHHHHHHHHHHTTC
T ss_pred             CCCCCCccccccCcCCCCCCCCcccCCccccccCCCCcccccccccCCCCCCCcCccccccccccCCccccCCCCCCCCC
Confidence               0000000000000000000000000000            000         000                      


Q ss_pred             ---------Ccccccccccccccc-------------ccccccccccchhhHHhhhhhHHHHHHHHHHHHhhhhhHHHHH
Q psy5093         299 ---------GITRQVSNTRIIHKG-------------HIVKNFSLSRKLSKFAKEKKAAKTLGIVMGVFIVCWLPFFVVN  356 (662)
Q Consensus       299 ---------~~~~~~~~~~~~~~~-------------~~~~~~~~~~~~~~~~~~~~~~~~l~~i~~~f~i~~~P~~i~~  356 (662)
                               .............+.             ..+.....+++++..++|+|++||+++++++|++||+|++++.
T Consensus       350 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~erk~~k~L~iVv~~F~iCWlPf~i~~  429 (510)
T 4grv_A          350 TNSLRMLNNKRWDEAAVNLAKSRWYNQTPNRAKRVITTFRTGTWDAYGSGSVQALRHGVLVARAVVIAFVVCWLPYHVRR  429 (510)
T ss_dssp             HHHHHHHTTTCHHHHHHHHHSSCSCCSSHHHHHHHHHHHHHSSSGGGTTSTTTHHHHHHHHHHHHHHHHHHHHHHHHHHH
T ss_pred             CccccccccCCCcccccccccccccccCCccccccccccccccchhhhHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
Confidence                     000000000000000             0000111223334456789999999999999999999999999


Q ss_pred             HHHHhhccccCCC---chhHHHHHHHHHHHHhhccccchhhhhcChhHHHHHHHhcccC
Q psy5093         357 LLSAVCTKCFWSE---QDEELISAVVTWLGWINSGMNPVIYACWSRDFRSKEKILNHKI  412 (662)
Q Consensus       357 ~~~~~~~~~~~~~---~~~~~~~~~~~~l~~~ns~~nP~IY~~~~~~fR~~~~~l~~~~  412 (662)
                      ++..+.++.....   ....++..++.+|+|+||++||+||+++|++||+++|++++++
T Consensus       430 l~~~~~~~~~~~~~~~~~~~~~~~~~~~L~Y~NS~iNPiIY~~~n~~FR~aFk~iL~C~  488 (510)
T 4grv_A          430 LMFCYISDEQWTTFLFDFYHYFYMLTNALAYASSAINPILYNLVSANFRQVFLSTLACL  488 (510)
T ss_dssp             HHHHTTTTTCCCHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHSCCCCC--------
T ss_pred             HHHHHcCcccCChhHHHHHHHHHHHHHHHHHHHHHHHHHHHHhcCHHHHHHHHHHHhhc
Confidence            9987765433221   1234566788999999999999999999999999999987543



>3vw7_A Proteinase-activated receptor 1, lysozyme; high resolution structure, protease-activated receptor 1, in conformation, antagonist vorapaxar; HET: VPX OLC; 2.20A {Homo sapiens} Back     alignment and structure
>2rh1_A Beta-2-adrenergic receptor/T4-lysozyme chimera; GPCR, 7TM, fusion, lipidic cubic phase, lipidic, mesophase, cholesterol, membrane protein; HET: MAL CAU CLR PLM 12P; 2.40A {Homo sapiens} PDB: 3p0g_A* 3d4s_A* 3ny8_A* 3ny9_A* 3nya_A* 3pds_A* Back     alignment and structure
>3uon_A Human M2 muscarinic acetylcholine, receptor T4 LY fusion protein; G protein-coupled receptor, GPCR, SI protein-antagonist complex; HET: QNB BGC; 3.00A {Homo sapiens} PDB: 4daj_A* Back     alignment and structure
>3odu_A C-X-C chemokine receptor type 4, lysozyme chimera; structural genomics, PSI-2, protein structure initiative; HET: ITD OLC OLA; 2.50A {Homo sapiens} PDB: 3oe8_A* 3oe6_A* 3oe0_A* 3oe9_A* 2k03_B* 2k04_B 2k05_B* Back     alignment and structure
>3pbl_A D(3) dopamine receptor, lysozyme chimera; structural genomics, PSI-2, PSI-biology, protein structure initiative; HET: ETQ MAL; 2.89A {Homo sapiens} Back     alignment and structure
>3rze_A Histamine H1 receptor, lysozyme chimera; structural genomics, PSI-biology, membrane protein, GPCR NET GPCR, hydrolase; HET: 5EH D7V OLC; 3.10A {Homo sapiens} Back     alignment and structure
>3eml_A Human adenosine A2A receptor/T4 lysozyme chimera; caffeine, GPCR, membrane protein, LCP, mesophase, structural genomics, PSI-2; HET: ZMA STE; 2.60A {Homo sapiens} PDB: 3qak_A* Back     alignment and structure
>3v2y_A Sphingosine 1-phosphate receptor 1, lysozyme CHIM; EDG receptor, lipid receptor, multiple sclerosi autoimmunity, structural genomics, PSI-biology; HET: ML5 NAG; 2.80A {Homo sapiens} PDB: 3v2w_A* Back     alignment and structure
>4dkl_A MU-type opioid receptor, lysozyme chimera; G-protein coupled receptor, 7 transmembrane receptor, signal protein-antagonist complex; HET: BF0 CLR MPG 1PE; 2.80A {Mus musculus} PDB: 4ej4_A* 4djh_A* Back     alignment and structure
>2ks9_A Substance-P receptor; water, autodock, NK1, neuropeptide receptor-NEU complex; NMR {Homo sapiens} PDB: 2ksa_A 2ksb_A Back     alignment and structure
>2lnl_A C-X-C chemokine receptor type 1; G protein coupled receptor, GPCR, membrane protei transmembrane, 7TM, phospholipid, signaling, signaling PROT; NMR {Homo sapiens} Back     alignment and structure
>2z73_A Rhodopsin; visual pigment, GQ-type, G-protein coupled receptor, chromophore, glycoprotein, lipoprotein, membrane, palmitate phosphorylation; HET: BOG RET PLM TWT PC1; 2.50A {Todarodes pacificus} PDB: 3aym_A* 3ayn_A* 2ziy_A* Back     alignment and structure
>1u19_A Rhodopsin; G protein-coupled receptor, membrane protein, retinal protei photoreceptor, signaling protein; HET: MAN NAG BMA RET PLM HTO HTG; 2.20A {Bos taurus} SCOP: f.13.1.2 PDB: 1hzx_A* 1gzm_A* 1l9h_A* 2g87_A* 2hpy_A* 2i35_A* 2i36_A* 2i37_A* 2ped_A* 3oax_A* 3c9l_A* 1jfp_A* 1ln6_A* 1f88_A* 3cap_A* 3dqb_A* 3pqr_A* 3pxo_A* 3c9m_A* 2x72_A* ... Back     alignment and structure
>4eiy_A Adenosine receptor A2A/soluble cytochrome B562 CH; novel protein engineering, GPCR network, PSI-biology, struct genomics, membrane protein, GPCR; HET: ZMA CLR OLA OLC OLB; 1.80A {Homo sapiens} PDB: 3vg9_A* 3vga_A* 2ydv_A* 2ydo_A* 3uza_A* 3rey_A* 3rfm_A* 3pwh_A* 3uzc_A* 4er9_A Back     alignment and structure
>4amj_A Beta-1 adrenergic receptor; membrane protein, 7TMR BETA1-adrenoceptor, stabilising mutat biased agonist; HET: CVD 2CV; 2.30A {Meleagris gallopavo} PDB: 2y01_A* 2y02_A* 2y03_A* 2y04_A* 4ami_A* 2y00_A* 2vt4_A* 2ycw_A* 2ycx_A* 2ycy_A* 2ycz_A* Back     alignment and structure
>3sn6_R Lysozyme, beta-2 adrenergic receptor; seven transmembrane receptor, nanobody, G protein-coupled RE GPCR, signal transduction, G protein signaling; HET: P0G; 3.20A {Enterobacteria phage T4} PDB: 3kj6_A 2r4s_A 2r4r_A 4gbr_A* Back     alignment and structure
>4grv_A Neurotensin receptor type 1, lysozyme chimera; G-protein coupled receptor, G-protein, signaling protein-agonist complex; HET: EPE; 2.80A {Rattus norvegicus} Back     alignment and structure
>3vw7_A Proteinase-activated receptor 1, lysozyme; high resolution structure, protease-activated receptor 1, in conformation, antagonist vorapaxar; HET: VPX OLC; 2.20A {Homo sapiens} Back     alignment and structure
>2rh1_A Beta-2-adrenergic receptor/T4-lysozyme chimera; GPCR, 7TM, fusion, lipidic cubic phase, lipidic, mesophase, cholesterol, membrane protein; HET: MAL CAU CLR PLM 12P; 2.40A {Homo sapiens} PDB: 3p0g_A* 3d4s_A* 3ny8_A* 3ny9_A* 3nya_A* 3pds_A* Back     alignment and structure
>3uon_A Human M2 muscarinic acetylcholine, receptor T4 LY fusion protein; G protein-coupled receptor, GPCR, SI protein-antagonist complex; HET: QNB BGC; 3.00A {Homo sapiens} PDB: 4daj_A* Back     alignment and structure
>3v2y_A Sphingosine 1-phosphate receptor 1, lysozyme CHIM; EDG receptor, lipid receptor, multiple sclerosi autoimmunity, structural genomics, PSI-biology; HET: ML5 NAG; 2.80A {Homo sapiens} PDB: 3v2w_A* Back     alignment and structure
>3odu_A C-X-C chemokine receptor type 4, lysozyme chimera; structural genomics, PSI-2, protein structure initiative; HET: ITD OLC OLA; 2.50A {Homo sapiens} PDB: 3oe8_A* 3oe6_A* 3oe0_A* 3oe9_A* 2k03_B* 2k04_B 2k05_B* Back     alignment and structure
>3rze_A Histamine H1 receptor, lysozyme chimera; structural genomics, PSI-biology, membrane protein, GPCR NET GPCR, hydrolase; HET: 5EH D7V OLC; 3.10A {Homo sapiens} Back     alignment and structure
>3eml_A Human adenosine A2A receptor/T4 lysozyme chimera; caffeine, GPCR, membrane protein, LCP, mesophase, structural genomics, PSI-2; HET: ZMA STE; 2.60A {Homo sapiens} PDB: 3qak_A* Back     alignment and structure
>4dkl_A MU-type opioid receptor, lysozyme chimera; G-protein coupled receptor, 7 transmembrane receptor, signal protein-antagonist complex; HET: BF0 CLR MPG 1PE; 2.80A {Mus musculus} PDB: 4ej4_A* 4djh_A* Back     alignment and structure
>3pbl_A D(3) dopamine receptor, lysozyme chimera; structural genomics, PSI-2, PSI-biology, protein structure initiative; HET: ETQ MAL; 2.89A {Homo sapiens} Back     alignment and structure
>2z73_A Rhodopsin; visual pigment, GQ-type, G-protein coupled receptor, chromophore, glycoprotein, lipoprotein, membrane, palmitate phosphorylation; HET: BOG RET PLM TWT PC1; 2.50A {Todarodes pacificus} PDB: 3aym_A* 3ayn_A* 2ziy_A* Back     alignment and structure
>4eiy_A Adenosine receptor A2A/soluble cytochrome B562 CH; novel protein engineering, GPCR network, PSI-biology, struct genomics, membrane protein, GPCR; HET: ZMA CLR OLA OLC OLB; 1.80A {Homo sapiens} PDB: 3vg9_A* 3vga_A* 2ydv_A* 2ydo_A* 3uza_A* 3rey_A* 3rfm_A* 3pwh_A* 3uzc_A* 4er9_A Back     alignment and structure
>3sn6_R Lysozyme, beta-2 adrenergic receptor; seven transmembrane receptor, nanobody, G protein-coupled RE GPCR, signal transduction, G protein signaling; HET: P0G; 3.20A {Enterobacteria phage T4} PDB: 3kj6_A 2r4s_A 2r4r_A 4gbr_A* Back     alignment and structure
>2lnl_A C-X-C chemokine receptor type 1; G protein coupled receptor, GPCR, membrane protei transmembrane, 7TM, phospholipid, signaling, signaling PROT; NMR {Homo sapiens} Back     alignment and structure
>2ks9_A Substance-P receptor; water, autodock, NK1, neuropeptide receptor-NEU complex; NMR {Homo sapiens} PDB: 2ksa_A 2ksb_A Back     alignment and structure
>4amj_A Beta-1 adrenergic receptor; membrane protein, 7TMR BETA1-adrenoceptor, stabilising mutat biased agonist; HET: CVD 2CV; 2.30A {Meleagris gallopavo} PDB: 2y01_A* 2y02_A* 2y03_A* 2y04_A* 4ami_A* 2y00_A* 2vt4_A* 2ycw_A* 2ycx_A* 2ycy_A* 2ycz_A* Back     alignment and structure
>1u19_A Rhodopsin; G protein-coupled receptor, membrane protein, retinal protei photoreceptor, signaling protein; HET: MAN NAG BMA RET PLM HTO HTG; 2.20A {Bos taurus} SCOP: f.13.1.2 PDB: 1hzx_A* 1gzm_A* 1l9h_A* 2g87_A* 2hpy_A* 2i35_A* 2i36_A* 2i37_A* 2ped_A* 3oax_A* 3c9l_A* 1jfp_A* 1ln6_A* 1f88_A* 3cap_A* 3dqb_A* 3pqr_A* 3pxo_A* 3c9m_A* 2x72_A* ... Back     alignment and structure
>2koe_A Human cannabinoid receptor 1 - helix 7/8 peptide; GPCR, HCB1, membrane protein, signaling protein; NMR {Homo sapiens} Back     alignment and structure
>2koe_A Human cannabinoid receptor 1 - helix 7/8 peptide; GPCR, HCB1, membrane protein, signaling protein; NMR {Homo sapiens} Back     alignment and structure
>2ki9_A Cannabinoid receptor 2; GPCR, G-protein coupled receptor, membrane protein; NMR {Synthetic} Back     alignment and structure
>1hll_A Alpha-2A adrenergic receptor; helix-linker-helix, membrane protein; NMR {Synthetic} SCOP: j.94.1.1 PDB: 1hof_A 1ho9_A 1hod_A Back     alignment and structure
>2ki9_A Cannabinoid receptor 2; GPCR, G-protein coupled receptor, membrane protein; NMR {Synthetic} Back     alignment and structure
>2lot_A Apelin receptor; membrane protein; NMR {Homo sapiens} PDB: 2lou_A 2lov_A 2low_A Back     alignment and structure
>2ket_A Cathelicidin-6; antimicrobial peptide, antibiotic, antimicrobial, fungicide, pyrrolidone carboxylic acid, secreted; NMR {Bos taurus} Back     alignment and structure

Homologous Structure Domains

Structure Domains Detected by RPS-BLAST ?

ID ?Alignment Graph ?Length ? Definition ? E-value ?
Query 662
d1u19a_348 f.13.1.2 (A:) Rhodopsin {Cow (Bos taurus) [TaxId: 2e-18
d1u19a_348 f.13.1.2 (A:) Rhodopsin {Cow (Bos taurus) [TaxId: 3e-09
d1u19a_348 f.13.1.2 (A:) Rhodopsin {Cow (Bos taurus) [TaxId: 8e-09
>d1u19a_ f.13.1.2 (A:) Rhodopsin {Cow (Bos taurus) [TaxId: 9913]} Length = 348 Back     information, alignment and structure

class: Membrane and cell surface proteins and peptides
fold: Family A G protein-coupled receptor-like
superfamily: Family A G protein-coupled receptor-like
family: Rhodopsin-like
domain: Rhodopsin
species: Cow (Bos taurus) [TaxId: 9913]
 Score = 84.6 bits (208), Expect = 2e-18
 Identities = 41/232 (17%), Positives = 91/232 (39%), Gaps = 16/232 (6%)

Query: 13  DFFSNSSNWTYIDIDDDVVTYDFVSNFTLERWLELAQQRTLLVSTLSLFSLVTVFGNALV 72
           +F+   SN T +        ++    +  E W     Q ++L + + L  ++    N L 
Sbjct: 8   NFYVPFSNKTGVVRS----PFEAPQYYLAEPW-----QFSMLAAYMFLLIMLGFPINFLT 58

Query: 73  MIAVVRERYLHTSTNYFIMSLALADCLVGLVVMPFSALYELLDHNWIFGLNWCDSWRSLD 132
           +   V+ + L T  NY +++LA+AD  +       +     L   ++FG   C+      
Sbjct: 59  LYVTVQHKKLRTPLNYILLNLAVADLFMVFGGFTTTLYT-SLHGYFVFGPTGCNLEGFFA 117

Query: 133 VLFSTASILNLCVISLDRYWAITDPLTYPSRMSTRRAYIWIAIVWICSGGISFPAILWWR 192
            L    ++ +L V++++RY  +  P++                  +     + P + W R
Sbjct: 118 TLGGEIALWSLVVLAIERYVVVCKPMSNFRFGENHAIMGVAFTWVMALACAAPPLVGWSR 177

Query: 193 AVRN------EEVPKNKCPFTDSKGYLIFSSTISFYLPLLVMVFTYFKIYRA 238
            +                  T+++ ++I+   + F +PL+V+ F Y ++   
Sbjct: 178 YIPEGMQCSCGIDYYTPHEETNNESFVIYMFVVHFIIPLIVIFFCYGQLVFT 229


>d1u19a_ f.13.1.2 (A:) Rhodopsin {Cow (Bos taurus) [TaxId: 9913]} Length = 348 Back     information, alignment and structure
>d1u19a_ f.13.1.2 (A:) Rhodopsin {Cow (Bos taurus) [TaxId: 9913]} Length = 348 Back     information, alignment and structure

Homologous Domains Detected by HHsearch ?

ID ?Alignment Graph ?Length ? Definition ? Probability ?
Query662
d1u19a_348 Rhodopsin {Cow (Bos taurus) [TaxId: 9913]} 100.0
d1u19a_348 Rhodopsin {Cow (Bos taurus) [TaxId: 9913]} 99.73
>d1u19a_ f.13.1.2 (A:) Rhodopsin {Cow (Bos taurus) [TaxId: 9913]} Back     information, alignment and structure
class: Membrane and cell surface proteins and peptides
fold: Family A G protein-coupled receptor-like
superfamily: Family A G protein-coupled receptor-like
family: Rhodopsin-like
domain: Rhodopsin
species: Cow (Bos taurus) [TaxId: 9913]
Probab=100.00  E-value=5.6e-35  Score=295.91  Aligned_cols=285  Identities=19%  Similarity=0.347  Sum_probs=225.1

Q ss_pred             HhHHHHHHHHHHHHHHHHHHhhHhhhhheeccccccchhhHHHHHHHHHHHhhhhhcccHHHHHhhccccccccccchhH
Q psy5093          48 AQQRTLLVSTLSLFSLVTVFGNALVMIAVVRERYLHTSTNYFIMSLALADCLVGLVVMPFSALYELLDHNWIFGLNWCDS  127 (662)
Q Consensus        48 ~~~~~i~~~~~~ii~i~gl~gN~~vi~~i~~~~~lr~~~~~ll~~Lai~Dll~~l~~~p~~~~~~~~~~~~~~~~~~C~~  127 (662)
                      ++...++++++.+++++|++||+++++++.++|++|++.|++++|||++|++.++..+|..+.... .+.|..+...|+.
T Consensus        34 ~~~~~~~~~~~~ii~v~gi~gN~lvi~vi~~~k~lr~~~~~~l~nLaiaDll~~~~~~~~~~~~~~-~~~~~~~~~~c~~  112 (348)
T d1u19a_          34 PWQFSMLAAYMFLLIMLGFPINFLTLYVTVQHKKLRTPLNYILLNLAVADLFMVFGGFTTTLYTSL-HGYFVFGPTGCNL  112 (348)
T ss_dssp             HHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHSTTCCSHHHHHHHHHHHHHHHHHHHTHHHHHHHHH-HTSCTTHHHHHHH
T ss_pred             HHHHHHHHHHHHHHHHHHHHHHHHeehhhhccCCCCCHhHHHHHHHHHHHHHHHHHHHHHhhhhhc-cCccccCchhhhh
Confidence            445678889999999999999999999999999999999999999999999998888886555444 5678888999999


Q ss_pred             HHHhhHHHHHHHHHHHHHHHHHHhhhhcCCCCCCccccchhhhHHHHHHHHHHHhhhhhHHHhhhccccCCCCCCccccC
Q psy5093         128 WRSLDVLFSTASILNLCVISLDRYWAITDPLTYPSRMSTRRAYIWIAIVWICSGGISFPAILWWRAVRNEEVPKNKCPFT  207 (662)
Q Consensus       128 ~~~~~~~~~~~s~~~l~~iaidRy~~I~~P~~y~~~~t~~~~~~~i~~~w~~s~~~~~~~~~~~~~~~~~~~~~~~c~~~  207 (662)
                      ..++..++..++.++++++++|||++|++|++|+. .++++....++.+|.+++++..++.+.......... ...|...
T Consensus       113 ~~~~~~~~~~~s~~~l~~is~~R~~~i~~p~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~  190 (348)
T d1u19a_         113 EGFFATLGGEIALWSLVVLAIERYVVVCKPMSNFR-FGENHAIMGVAFTWVMALACAAPPLVGWSRYIPEGM-QCSCGID  190 (348)
T ss_dssp             HHHHHHHHHHHHHHHHHHHHHHHHHHHTCCSSSCC-CCHHHHHHHHHHHHHHHHHHHSGGGTTSSCCEEETT-TTEEECC
T ss_pred             hhhccccceeeecchhhhhhcccceeeeccccccc-cccccccccceeeehhhhheecccccccceeccCCc-ccccccc
Confidence            99999999999999999999999999999999765 467777788888899999988888877655433332 2222111


Q ss_pred             --------CCcchhhhhHHHHHHHHHHHHHHHHHHHHHHHHHHhhccccCCcccccCCCCCCccceeeeccCCCCCCCCc
Q psy5093         208 --------DSKGYLIFSSTISFYLPLLVMVFTYFKIYRAAVVQTKSLKVGTKQVMSGSTSGEKELTLRIHRGGTDHRHMT  279 (662)
Q Consensus       208 --------~~~~~~~~~~~~~~~ip~~ii~~~y~~I~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  279 (662)
                              ....+..+...+.+++|+++++++|.++.+.++++.++.                                 
T Consensus       191 ~~~~~~~~~~~~~~~~~~~~~~~ip~~i~~~~y~~i~~~~~~~~~~~---------------------------------  237 (348)
T d1u19a_         191 YYTPHEETNNESFVIYMFVVHFIIPLIVIFFCYGQLVFTVKEAAAQQ---------------------------------  237 (348)
T ss_dssp             CSCCCGGGTHHHHHHHHHHHTTHHHHHHHHHHHTTTTTSSCSCCCSS---------------------------------
T ss_pred             cccccccccchhhHHHHHHHHHHHHHHHHHHHHHHHHhhhccccccc---------------------------------
Confidence                    122244555666778899999999999877654332211                                 


Q ss_pred             cCCCCCCccccccccccCCCccccccccccccccccccccccccchhhHHhhhhhHHHHHHHHHHHHhhhhhHHHHHHHH
Q psy5093         280 LHHTPSDDVEMDNVMSGHNGITRQVSNTRIIHKGHIVKNFSLSRKLSKFAKEKKAAKTLGIVMGVFIVCWLPFFVVNLLS  359 (662)
Q Consensus       280 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~i~~~f~i~~~P~~i~~~~~  359 (662)
                                                                +....+.++++|+++++++++++|++||+|+.+..++.
T Consensus       238 ------------------------------------------~~~~~~~~~~~~~~~~~~~i~~~f~~~~~P~~i~~~~~  275 (348)
T d1u19a_         238 ------------------------------------------QESATTQKAEKEVTRMVIIMVIAFLICWLPYAGVAFYI  275 (348)
T ss_dssp             ------------------------------------------CSSSHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
T ss_pred             ------------------------------------------chhhhhHHHHhhHhheEEEeehHHHHHhhHHHhhhhee
Confidence                                                      01112334789999999999999999999999988877


Q ss_pred             HhhccccCCCchhHHHHHHHHHHHHhhccccchhhhhcChhHHHHHHHhcccCCc
Q psy5093         360 AVCTKCFWSEQDEELISAVVTWLGWINSGMNPVIYACWSRDFRSKEKILNHKISP  414 (662)
Q Consensus       360 ~~~~~~~~~~~~~~~~~~~~~~l~~~ns~~nP~IY~~~~~~fR~~~~~l~~~~~~  414 (662)
                      ...+.    .........+..++.++|+++||+||+++|++||+++++++|+.++
T Consensus       276 ~~~~~----~~~~~~~~~~~~~l~~~ns~iNPiIY~~~~~~fR~~~~~~l~c~~~  326 (348)
T d1u19a_         276 FTHQG----SDFGPIFMTIPAFFAKTSAVYNPVIYIMMNKQFRNCMVTTLCCGKN  326 (348)
T ss_dssp             HHTTT----SCCCHHHHHHHHHHGGGGGTHHHHHHHHTCHHHHHHHHHHHTSSCC
T ss_pred             eccCC----ccccHHHHHHHHHHHHHHHHHHHHHHHhcCHHHHHHHHHHhCCCCC
Confidence            66543    3334566778889999999999999999999999999988764443



>d1u19a_ f.13.1.2 (A:) Rhodopsin {Cow (Bos taurus) [TaxId: 9913]} Back     information, alignment and structure